CN1107687A - 用于吸入装置的药物包 - Google Patents

用于吸入装置的药物包 Download PDF

Info

Publication number
CN1107687A
CN1107687A CN94116778A CN94116778A CN1107687A CN 1107687 A CN1107687 A CN 1107687A CN 94116778 A CN94116778 A CN 94116778A CN 94116778 A CN94116778 A CN 94116778A CN 1107687 A CN1107687 A CN 1107687A
Authority
CN
China
Prior art keywords
cover plate
wheel
substrate
pharmaceutical pack
tooth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN94116778A
Other languages
English (en)
Other versions
CN1066036C (zh
Inventor
迈克尔·伯沙·戴维斯
戴维·约翰·赫恩
保罗·肯尼思·兰德
理查德·伊恩·沃克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GLAXO
Glaxo Group Ltd
Original Assignee
GLAXO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GLAXO filed Critical GLAXO
Publication of CN1107687A publication Critical patent/CN1107687A/zh
Application granted granted Critical
Publication of CN1066036C publication Critical patent/CN1066036C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0043Non-destructive separation of the package, e.g. peeling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0051Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0053Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type or way of disposal
    • A61M15/0055Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type or way of disposal the used dosages being coiled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • A61M15/0068Indicating or counting the number of dispensed doses or of remaining doses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • A61M15/0068Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007Mechanical counters
    • A61M15/0071Mechanical counters having a display or indicator
    • A61M15/0075Mechanical counters having a display or indicator on a disc
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • A61M15/0068Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007Mechanical counters
    • A61M15/0071Mechanical counters having a display or indicator
    • A61M15/0078Mechanical counters having a display or indicator on a strip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00Characteristics of a physical parameter; associated device therefor
    • A61M2206/10Flow characteristics
    • A61M2206/16Rotating swirling helical flow, e.g. by tangential inflows

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Basic Packing Technique (AREA)
  • Steroid Compounds (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Abstract

一种与吸入装置一起使用的药物包(401),该药 物包上至少有一个容装粉状药物的容器形成在可剥 开地相互固定在一起的两片薄片(403、404)之间。 该吸入装置包含在一打开位置用于剥开薄片以打开 容器的装置,和一个与该打开的容器连通的出口,通 过该出口,使用者可从已打开的容器中吸入粉状的药 物。

Description

本申请为在1991年3月1日提交的、申请号为91101342.3的、发明名称为“吸入装置”的发明专利申请的分案。
原申请91101342.3描述并请求保护一种跟药物包一起使用的吸入装置,在该药物包内至少有一个由两个可剥开地相互固定在一起的部件限定的装粉状药物的容器;该吸入装置包含有对所述至少一个容器限定一个开口位置的装置、在该开口位置用以剥开药物包的两个部件以打开该容器的装置、和一个跟已打开的容器相连通使使用者能从已打开的容器吸入粉状药物的出口。
本发明涉及一种跟一种通过它使用者可吸入粉状药物的吸入装置一起使用的药物包。
跟药物以粉状形式保存在泡囊内的泡囊包一起使用的吸入装置是公知的。这样的装置包括一个依次刺破每个泡囊以使药物能从其中吸出的穿刺元件。本发明的目的在于提供一种具有很多分立的单位剂量的、跟原申请91101342.3中所描述的吸入装置一起使用的药物包。
可剥开的配用包是公知的。GB1048672(Diamant)描述了一种成带状的配用包,其中待配用的物质装在形成在两排包皮之内或在一排可剥开的包皮与一条带之间的空腔内。
GB1019963(Bodet)描述了一种由两片粘结在一起的片材形成并设计成可用人手剥开的泡囊包。该泡囊包成形成提供多排通过在片材中平行于每排的横向切痕之间的小桥接部相互分开的泡囊。每排泡囊可以独立于其它排来打开。
上述两个公开件涉及带有多剂粉状药物的药物包的使用。但是,在这两个公开件中并没有揭示这些药物包可以用于可吸入的药粉,并且难以预料到任何可以用于方便地从这样的药粉包吸入粉状药物的装置。
根据本发明,提供了一种用于吸入装置内的药物包,该药物包包含一条由一片具有多个沿其长度隔开设置的凹腔的基片和一片可剥开地气密封接在基片上以构成多个容器的密封盖片形成的长形带,每个容器内具有粉状的吸入药物。该长形带最好是足够地柔软,以便缠绕成卷。
下面结合附图和实施例对本发明进行详细的说明,其中:
图1是跟本发明的药物包一起使用的吸入装置的第一实施例的后视图;
图2是图1所示实施例的各部件的轴测分解图;
图3a、3b和3c分别是一轴测图、一纵向截面图和一端视图(局部刻开),表示用在图1和图2所示实施例中的离合器;
图4a和4b分别是用比图1和图2更大比例表示的一接口件的轴向截面和横截面,该接口件可用在吸入装置的第一实施例中(或用在一些其它的实施例中);
图5是吸入装置的第二实施例的前视图,其上一个盖子已拆下以表示内部结构;
图6是吸入装置的第二实施例的后视图,但表示了其内部结构;
图7是吸入装置的第二实施例的轴测前视图;
图8是吸入装置的第二实施例的轴测后视图;
图9是吸入装置的第二实施例的轴测分解图;
图10是吸入装置的第三实施例的前视图;用以显示其内部结构;
图11是一放大比例的轴向视图,表示吸入装置的第三实施例的接口件;
图12是吸入装置的第三实施例的仰视图;
图13至图16表示吸入装置的第四个实施例,图13是底平面视图,图14是沿图13中B-B线截取的一个截面,图15是沿图13中A-A线截取的一个截面,图16是以较小比例示出的分解图;
图16a至16d示出吸入装置的第四实施例在连续的工作步骤情况下的视图,图16e是图16a中沿A-A线截取的截面;
图17到20表示吸入装置的第五实施例,图17是一端视图,图18是图17中沿A-A线截取的一个截面,图19是图17中沿B-B线截取的一个截面,图20是一个分解图;
图21至24表示吸入装置的第六实施例,图21是一个端视图,图22是图21中沿A-A线截取的一个截面,图23是图21中沿B-B线截取的一个截面图,图24是一个分解图;
图25至29表示一个改进的离合器,该离合器可以用在吸入装置需用的一些实施例中,这些图分别是一前视图,一俯视图,一后视图,一左侧视图和一个轴测视图;
图30是一个分解的透视图,表示可以使用的离合器的另一实施例;
图31是可以使用的离合器的又一个实施例的分解透视图;
图31a是图31中示出的离合器的横截面;
图32至34以后视图表示吸入装置的另一实施例的连续工作位置;
图35是本发明的药物包的一个实施例的放大透视图。
现在参考图1、2和3a至3c,这些图表示一个吸入药物的装置,其内装有一条构成许多凹腔2的挠性带1,每个凹腔容纳一剂可以被吸入的粉状药物。挠性带1包括一个其上形成有泡囊以构成凹腔2的基片3和一个除了泡囊范围之外气密封接在基片3上的盖片4,盖片4盖在基片上的方法使其能从基片上剥离开。这两个薄片除了在其上的前端部分之外在它们的整个宽度上相互密封,其前端部分最好相互完全不封住。盖片和基片各自最好由一塑料/铝层压薄片制成,并且该盖片和基片最好用热封法相互粘接。例如,盖片材料可以是由每平方米50克漂白牛皮纸/12微米聚酯(PETP)膜/20微米软化回火铝箔/每平方米9克乙烯可剥的热封胶膜(对聚氯乙烯是可封的)组成的层压薄片,基片材料可以是由100微米聚氯乙烯/45微米软化回火铝箔/25微米定向聚酰胺组成的层压薄片。盖片材料上的胶膜封接在基片材料的聚氯乙烯层上,以便在盖片和基片之间提供可剥离的封接。
图中所示的挠性带具有多个相对于挠性带长度横向延伸的长形空腔。这样便于在一给定长度的挠性带上能设置大量的凹腔。例如,这个挠性带上可设置六十或一百个凹腔,但应当理解到,该挠性带可以设置任何合适数量的凹腔。
该吸入药物的装置包括一个构成三个贮放室的壳体10,即一个用以将挠性带1最初装在其内并从那里发送出来的腔室11,一个用于容纳基片3用过部分的腔室12,和一个用于在其内将用过的盖片部分缠绕在一个盖片轮14上的腔室13。腔室11和12带有各自弯曲的簧片28和29,其用途在下面进行说明。该壳体确定了另一放置分度轮16的腔室15。分度轮具有许多平行于其轴线延伸的槽17。这些槽以一个等于两相邻凹腔2的中心线之间的距离的节距间隔开。腔室11、12、13和15都由盖子30封住。腔室15分别通过通道31、33和32与腔室11、12和13连通。
腔室15与一缝隙18相通,该缝隙又向上伸入一接口件20内。该缝隙18还与各空气入口相连通,这方面内容将在下面参图4a和4b中所示的具体的接口件进行说明。接口件20设有附加的空气入口21。虽然这些入口可以是一些其它的形状,但这里所示的是一对如图4a和4b所示的圆孔形的入口。虽然这些附加空气入口21可以用作一个或更多的附加用途,但在图4a和4b中所示的空气入口的主要用途是为使用者提供附加的空气,并由此减少吸入的阻力,这部分内容将参考那些附图在下面进行说明。
该吸入装置没有一种装置,通过该装置,使用者可以一预定大小的步距转动分度轮和盖片轮。该装置包括一个棘轮22和一个齿轮23,它们连接起来与分度轮16一致地转动;一个安排成绕着与棘轮22和齿轮23相同的轴线转动,但独立于它们的手柄24;和一个与齿轮23啮合安排成转动盖片轮14的齿轮25。手柄24带有一个推杆26,它的端部与棘轮22的齿啮合。该棘轮的齿还与一个牢固地固定在壳体10上的棘爪27啮合。由于这些原因,从下面描述的这个实施例的工作情况可以清楚地看出,齿轮25不直接与盖片轮14连接,而是通过一个安装在盖片轮14内的滑动离合器50连接。设置这种离合器的作用是当转动盖片轮要求的力超过一预定值时,在盖片轮和齿轮25之间出现滑动。
离合器50包括一个配置有径向伸出锯齿52或其它粗糙表面的圆盘51,该锯齿或粗糙表面的作用是用一压缩弹簧54保持与配置在盖片轮14的一个端面上的类似锯齿或粗糙表面53相啮合。弹簧54的一端顶在盖轮的向内导入的表面55上,另一端顶在旋紧在螺栓57上的螺母56上。
上述的装置可以制成在凹腔2内容纳的药物都发放完之后可重复使用的结构。在那种情况下,该装置可以制成使使用者再次利用该装置的内部,例如,取下盖子30,装入一条新的挠性带1,例如以一装填式盒的形式。但是,该装置可以制成在该挠性带1提供的药物用尽时扔掉。
无论哪一种情况,当该装置第一次使用时,挠性带整体放在腔室11内,由簧片28压成一个相当紧的卷盘,其前端处的一个短部通过通道31穿出通向分度轮16。该挠性带前端的最前部分被剥离开,以便盖片4的前端可以固定在盖片轮14上,从而使基片3的前端可以进入通道33。盖片4的端部由一键34保持在盖片轮14上的适当位置上,键34与盖片轮14上的槽35进行压配合。
需要使用该装置的使用者按图1所示逆时针方向推手柄24,从而使推杆26将棘轮22推过等于与两相邻齿之间角向距离的角度。这就使分度轮16转过一个与槽17的节距相等并由此与挠性带上两个相邻的空腔2之间的距离相等的角位移。这就使得一个凹腔2与壳体10上的缝隙18相对。由于棘轮22和齿轮23同步运动,并由于齿轮25与齿轮23啮合,所以手柄24的运动也使盖片轮14转动。这样就将盖片4从基片3上剥开一足够的部分,以便露出与缝隙18对准的凹腔2的内含物。
当使用者通过接口件20吸入时,产生的空气流从打开的凹腔中吸入药粉,使这些药粉被使用者吸入。可能产生这种吸入的一种方法在下面参考图4a和4b中所示的接口件实施例更详细地说明。上述过程每重复一次,盖片的又一长度缠绕在盖片轮14上,并且基片的又一长度通过通道33进入腔室12。其内的簧片29保证该基片卷成圈并不会在腔室12的壁部上绊住。
在盖片轮14上缠绕盖片的一个结果是该轮子加上缠绕在其上的盖片的外径逐渐增大。如果这它不是使用滑动离合器将齿轮25连接到盖片轮14上的话,这种缠绕将使手柄24的连续操作试图导致将更长的盖片长度逐渐地缠绕在盖片轮上的结果。但是,该滑动离合器50避免了这种结果,该离合器每次通过的量足以保证对手柄的每次操作使盖片缠绕在其上的量精确地等于凹腔2的节距。
图4a和4b表示其内带有一个凹腔2的分度轮16的一部分,其中连带着一个稍微与图1至图3中所示的接口件不同并用标号120表示的接口件。接口件120具有空气入口140,概括地说涉及它的内容已结合图1至3进行了说明;还具有一个中心药粉出口119,它的一端通向凹腔2,它的另一端通入接口件120的内部。
当使用者通过该接口件120吸气时,引起空气通过入口140流入,然后通过凹腔2进入药粉出口119,并由接口件120流出。如此引导的通过凹腔2的空气流动达到了在空气流中有效地夹带药粉的目的,因而有效地吸空该凹腔。接口件120设有附加的空气入口121,图中所示的该例子中表示了四个入口,它们切向通入该接口件。当使用者吸气时,空气不仅通过空气入口140,而且通过空气入口121吸入接口件内,而且由入口121进入的空气产生一个涡旋的空气流,该空气流有助于在空气流中有效地分布药粉,并减少药粉沉积在该接口件内侧的程度。这种涡旋的空气流也有助于打碎可能存在于泡囊中的药粉的一些团块。
另一种离合器结构表示在图25至29中。在这种结构中,分度轮16和盖片轮14分别带有固定在它们上面用于一起转动的齿轮63和64。转动的方向如图27中的箭头所示。
齿轮63具有齿面65,使齿始终绕着齿面65并以一恒定的节距连续地设置。而齿轮64具有齿面66,由于径向延伸的几个狭槽67使其失去了一些齿。在齿面66上每个狭槽的周向宽度等于一个齿节。这些图上表示了三个这种狭槽。但是应当理解到,可以以一个狭槽、二个狭槽或多于三个的狭槽来取而代之。在每个狭槽67的一侧,实际上是考虑每个狭槽在齿轮64的转动方向的上游端一侧,一个带齿部分68限定在狭槽67和一条窄缝69之间。每条窄缝69的径向内端与一个孔70连通,使每个切齿部分68仅由一个杆部71与齿轮64的其余部分连接。齿轮64,或者至少配置有杆部71的那部分是由允许带齿部分68在圆周方向弹性地前后挠曲的材料制成。带齿部分68的其余部分如图所示,但当一个力按齿轮64的转动方向施加在一个带齿部分68上时,该带齿部分68可以位移,使狭槽67在其径向外端关闭。这种结构的效果是使失去齿的位置不在狭槽67的端部,而是在窄缝69的端部。
当由齿轮63施加在齿轮64上的圆周力低于一预定值时,带齿部分68保持在它的原来位置并且齿轮64的运转正如它具有一类似于齿轮63式的连续齿面一样。但是,如果载荷超过一预定值,带齿部分68与齿轮63每啮合一次,它就发生周向位移,在它的外端关闭狭槽67并打开窄缝69。这种带齿部分68通过与齿节相等的距离的位移具有产生齿轮64相对于齿轮63的滑转等于一个齿节的效果。这样,例举的结构能在每一转使这些齿轮彼此之间滑动的最大距离的总量等于齿节的三倍,因此引起盖片轮和分度轮彼此之间的相应滑转。可以理解到,设置的带齿部分多于或少于例举的三个将产生多于或少于这个最大的滑动量。
吸入药物的装置的第二个实施例表示在图5至9中。该实施例是打算用于除了凹腔的间隔之外(这部分内容见下面的说明)与用在第一实施例中的挠性带1相似的挠性带201的装置。在许多方面第二实施例中大致对应于第一实施例中的特定部件的部件用相同的标号表示,但使其加上数字200。第一实施例和第二实施例之间的主要差别在于后者没有对应于第一实施例中的分度轮16的分度轮。代替挠性带1转位,保证手柄的每次操作使挠性带前进的量等于凹腔节距的装置是由一终止在与相邻凹腔之间啮合的齿252上的弹性挠性杆250实现的。手柄224每操作一次,随着一个凹腔滑过齿252,挠性杆250就被弹性地压下,然后该齿弹回与挠性带上刚通过的凹腔后面相啮合。
显然,正如第一实施例中的情况,在操作过程中,其上缠有盖片的盖片轮214的直径逐渐地增大。由于滑动离合器不能用在这个实施例上,所以上述的效果由朝着挠性带后端逐渐增加的凹腔2的间隔来补偿。
在第一和第二实施例之间的另一个不同点在于后者中腔室211和212形成一个单一的复合腔室,不象在第一实施例中的分开的腔室11和12。但是,并不一定要如此,第一实施例可以使用一个单一的复合腔室,第二实施例也可以使用分开的两个腔室。
图10至12表示吸入装置的第三个实施例,在许多方面该实施例与第一实施例是相同的,在第三实施例中对应于第一实施例中的部件用相同的标号表示,但其加上另一数字300。
第二和第三实施例之间的一个明显的差别是使用了一对轮子314a和314b来代替盖片轮14,盖片被夹在轮子314a和314b之间的轮隙中,这对轮子起到一个碾压作用。这对轮子被滚花或设置其它粗糙表面,以改进这些轮子和盖片之间的啮合。用过的盖片不是缠绕起来,而是送入腔室313中,以便不会有当该装置连续的操作时盖片轮试图逐渐地缠绕更长的盖片长度的问题出现,正如在前面二个实施例中没有此问题一样。
图11表示稍微不同于图4a和4b中所示的接口件。所示的该接口件用单一的空气入口340代替成对的空气入口140,并且图4a和4b中的药粉出口119由减小宽度的接口件部分319所代替。但是,应该理解到,图10至12中所示的装置可以改型,以便安装一个更接近图4a和4b中所示的接口件。
图10表示的装置设有一个铰链盖360,并且这种盖可以用于前面二个实施例中的任何一个。图12表示带有一窗口370的装置,通过该窗口可看见挠性带上的指示。用印刷的方法使挠性带上带有与药物已被分发的凹腔数量有关的数字或其它指示,或另一种与待分发的凹腔有关的指示,以便为使用者提供已用去多少,或还剩下多少的指示。另一种可能性是使用一个由吸入装置的一个转动件驱动的剂量计数装置。值得注意的是,用于观察这些指示的类似标示和装置可以设置在所有的实施例上。
图13至16表示吸入装置的第四个实施例,其工作原理类似于第一实施例,并且在第四实施例中与第一实施例中对应的部件用相同的标号表示,但在其上加上数字400。
正如第一实施例一样,该装置容纳着一条挠性带,此处用401表示,它包括一条其上限定许多凹腔402的基片403和一盖片404。该挠性带401非常清楚地表示在图35中。盖片404在其前端形成有用于套连在从齿轮471(下面还要说明)向上伸出的柱471a上的环圈404a。基片具有一个用于啮合在基片缠绕轮470(下面将要说明)上形成的槽470a内的减小宽度的前部403a。基片和盖片的前端部分没有封接在一起,如图35中所示。
壳体410包括底部410a和顶部410b,两者基本上都是圆形的。当该装置装配时,底部和顶部按扣装配在一起。壳体限定了一个单一的内部腔室,挠性带401装在其内,并且其内还装有一个用于缠绕盖片404的用过部分的轮子414,以及基片缠绕轮470和分度轮416。分度轮416是空心的,一个分度棘轮422装在其内。刚才所述的所有轮子都装在由壳体限定的腔室内,以便进行相关的转动运动。棘爪470b装在壳体410上并与基片缠绕轮470的齿啮合,以防止该轮逆时针方向运动,由此保证挠性带401通过该装置仅可以向前运动。
盖片缠绕轮414由二部分形成,即带有齿472和轴473的齿轮471,和一个带有一空心中央轴475和多个弹性臂476的让缩轮474,例如,让缩轮可以是如图所示的从中央轴475各与半径成一角度伸出的八个这种臂。齿轮471具有一个凸块477,它与轴475上的对应槽啮合,以便齿轮471和让缩轮474一致地转动。
空心分度轮416具有与基片缠绕轮470的齿和齿轮471的齿啮合的外齿478。棘轮齿479在分度轮416的内壁上形成,并且该分度棘轮422具有两个与棘轮齿479相啮合的棘爪480。
该装置还有一个手柄424,它包括带有一个指形调整片482的弧形壁481和一个从该弧形壁481向内伸出并在其终端带有一排弧形齿484的壁483。该手柄枢转地安装在底部410a的中心,以便绕着在齿484的节距圆中心的轴线运动,该齿484与分度棘轮422上的齿485啮合。
一个集流管486设在壳体410内的腔室和一个接口件420之间的连通处。该集流管具有一个药粉出口419,还有一个通道487,从而使用过的盖片404可以通向让缩轮474。可选择地设置一个辊子488用以引导挠性带404进入通道487。
一个带有齿490的剂量指示环489可转动地安排在壳体底部410a上。在它的底部表面上有显示标记(图中未显示),这些标记可以由使用者通过壳体410上的窗口494观察到。从图16a至16d中以看到,当盖491(看下面)关闭和打开时都可以看到该窗口。这些标记不是精确地就是近似地表示剩下的剂量数目(或者,如果愿意的话表示用过的剂量数目)。指示环489由于它的齿490被分度轮的齿478啮合而转动。
该装置设置在盖491的下面,而盖491借助于壳体顶部410b上的一个凸块492和壳体底部410a上的一个对应的凸块493枢转地安装在壳体410上。该盖在一接口件露出的开启位置(见图14)和接口件未露出的关闭位置之间枢转,下面将更详细地说明。
在操作中,使用者将盖491移到其打开位置,然后压住手柄424的指形调整片,使它随着手柄的枢转而运动。这种操作使分度棘轮422转动,这种转动通过棘爪480使分度轮416也转动。分度轮416的转动产生基片缠绕轮470和盖片缠绕轮414二者的转动,由此在一足以露出在集合管486上的药粉出口419端部对面先前未打开的凹腔402的整个一段距离剥开基片和盖片。然后患者与前面的实施例一样通过接口件将药粉吸入。
该装置的连续操作步骤表示在图16a至16d中。在图16a中该装置处于关闭位置。在此步骤中手柄424的指形调整片482位于在壳体410内形成的一个凹座482b中(更清楚的参看图16b和16c)。当壳体410以逆时针方向转动时,盖491保持不动,为此目的在壳体的周缘上设有一凹部410c,以使使用者的一个手指插入。因此,该装置运动到图16b中表示的部分打开位置。在这个过程中,手柄424相对于盖491保持不动。这是通过在手柄内部设有一弹性臂424a,臂顶端424b啮合在盖491上的凹槽491a中实现的。弹性臂424a通过一个圆柱件424c连接在手柄424上。正如图16a中观察到的,臂424a从圆柱件424c逆时针方向伸出一个约90°的弧。圆柱件424c在壳体410上形成的一个弧形槽40d内引导。该槽410d贯穿约180°的圆弧,圆16a中示出圆柱件424c约位于沿其长度的中间位置。在图16b中所示的圆柱件位于一端。
使用者连续地将壳体410从图16b中所示的位置转动到图16c中所示的位置。在这个进一步转动的过程中,弹性臂424a的顶端424b跳出凹槽491a。这是由于圆柱件424c在槽410d的一端上,壳体410携带着圆柱件424c随着它一起按逆时针方向的运动,并由此强迫弹性臂424a也进行逆时针方向运动产生的。接着使用者通过推压指形调整片482推动手柄424,使它逆时针转动通过图16c所示的位置到达图16d所示的位置,在该位置指形调整片482再次进入凹座482b中。到此为止上述的这些步骤显露出接口件420并打开一个新的泡囊。因此,该装置现在已准备好给使用者吸入药物。
使用之后,壳体顺时针转动,手柄424与壳体一致地运动,转动到使该装置回到图16a所示的位置。
值得注意,让缩轮474实际上承担第一实施例中离合器的作用。当更多的盖片缠绕在轮474上时,臂476逐渐向内弯曲,并且这个作用保持缠绕盖片的卷盘外径大致恒定,而其内径逐渐减小。
用它的让缩轮474代替缠绕轮414,就有可能使用表示在图30或表示在图31和31a中的另一种结构。图30中所示的结构的工作原理非常类似于图25至29中所示的离合器装置。图30中的结构包括两个部件800和801。部件800包括一个大致圆柱形的其下底端开口的空心圆筒体802和三排弧形齿803。该圆筒体802具有一个贯穿上部表面的槽804和一个用于接受盖片前端的柱805。部件801包括一个其上带三排弧形齿807的圆盘806,和从该圆盘806向上伸出的立柱808。立柱808是由在扭转方面有弹性的材料制成的,例如由塑料材料制成。
两个部件800和801扣合装配在一起,使立柱808的上端套在槽804中并且相互间不会转动。齿排803和807是共平面的并相互交错。齿803和807与分度轮的齿478相啮合。每排齿807由相邻的一排齿803隔开(而不是由其它的),其间隙等于一个齿。因此,装配好的一圈齿排有三个间隙,每个间隙为一个齿宽。由于立柱808在扭转方向可以挠曲,所以圆盘806在对应的各排齿807的一侧上的间隙位置和对应的各排齿807的另一侧上的间隙位置之间自由地来回运动。这就具有图30中所示的结构,相对于分度轮产生滑动的效果。
图31中所示的结构是一个滑动离合器,它包括扣合装配在一起的两个部件810和811。部件810包括一个大致圆柱形的壳体812,其底部开口并带有一个用于接受盖片前端的柱体813。壳体812的内部设有轴向延伸的锯齿814,如图31a所示。部件811包括一个从带有齿817的圆盘816向上伸出的圆柱815。齿817与分度轮的齿478啮合。圆柱815的外表面上设有一对尖部818,它们抵触地与锯齿814啮合。当由部件811施加给部件810的旋转力低于一预定值水平时,这些部件一起转动。但是,该圆柱是由一易于变形的材料,例如一塑料制成的,它可以发生径向变形,当该旋转力超过该预定的水平时,则发生变形使尖部818移过这些锯齿814。
虽然在图13和16中所示的实施例中,用或者不用图30和31中的变更型,基片跟盖片一样被缠绕,但在分度轮和基片缠绕轮之间没有必要有一个滑动离合器或类似装置。基片缠绕轮的直径是这样选择的,即基片开始只是非常松地缠绕,并在操作过程中增加该基片的缠绕紧度,但是任何时候都不能达到一个不能接受的水平。理论上,基片可以通过一个滑动离合器或类似装置准确地进行缠绕,盖片只是松散地缠绕,但实际上,由于盖片是平的,而且它比基片更薄,所以精确地缠绕盖片要容易得多。
图17至20以示意性的形式表示了一个有一些类似于图10至12中所示装置的装置的主要操作部件,即它是一个碾压装置。但是,应当理解到,图17至20未表示一个完整的装置,用于未使用过的挠性带和用过的基片的腔室被省略。在该实施例中对应于图10至12中实施例的特定部件用相同的标号表示,但在其上加上数字200。
图17至20所示的装置包括一对轮子514a和514b,它们具有在其上形成的啮合齿并起到与用过的盖片材料接触的碾压装置的作用。这种用过的盖片材料送入腔室513。轮514b是一个惰轮并由作用在支座596上的压缩弹簧推紧与轮514a相啮合,该支座支撑着轮514b。轮514a具有一个齿环598,它与在分度轮516上形成的齿597相啮合,该分度轮516完成的功能与第一实施例中分度轮16一样,并在腔室515中是可转动的。这些腔室都是在壳体510内形成的并且盖子530a和530b固定在这些腔室的相对的两侧上。由接口件520吸入药物。该装置由手柄524操纵,手柄通过推臂526转动分度轮516。
图21至24所示的实施例表示另一种型式的碾压装置,但它是一种盖片和基片都通过碾压轮的碾压装置。
图21至24所示的实施例包括一个限定一大致圆形腔室611的壳体610,和已固定在其上的盖子612a和612b。腔室611内可转动地安装有分度轮613及基片和盖片缠绕轮614,分度轮613和缠绕轮614上具有相互啮合的齿。分度轮613上带有槽615,可旋转地支撑在支架619上的盖片夹紧轮618也装在靠近槽615处集流管616的下游端。辊子619a安装在集流管616的后面,以引导盖片。
将挠性带601放在腔室611内,该带的主要部分开始时要围绕腔室的内壁卷绕。该带的前端通过引导件622和623之间绕过分度轮613的圆周的一部分,以含有药粉的凹腔与槽615相啮合。在挠性带与集流管616交汇的位置,该挠性带被剥离开,盖片通过该集流管的后面并绕过辊子619a,而基片由分度轮和集流管之间通过。在集流管之后,基片和盖片都从分度轮和盖片夹紧轮618之间通过,并由此被夹住。挠性带的前端被固定在基片和盖片缠绕轮614上。
在使用中,挠性带601借助于手柄624,通过一推杆626转动分度轮而前进,分度轮使基片和盖片缠绕轮产生相应地转动。基片和盖片的这种缠绕开始是松散的,但随着操作的进行其紧度增加,但该紧度不会到达不能接受的水平。盖片和基片在挠性带遇到集流管616的地方被剥离开,把一个新的药粉凹腔供给药粉出口617,通过接口件620药粉被吸入。
作为另一个特征,图32至34表示吸入装置带有标示器的一个实施例,该标示器向使用者表示使用者操作该装置的连续步骤。除了该标示器之外,该装置大致与图1至3中所示的实施例相同,并用相应的标号表示对应的部件。但有一些附加构件,从下面的说明中可以清楚地看到。
图32至34中所示的装置具有一个盖子700,它枢转地连接在该装置的其余部分上,用以绕轴701进行枢转运动。齿轮23和25,以及相关的部件由一后壁702盖住。该盖子盖住该装置的整个后部,但在图中为了便于理解,除了一小部分外,其余的都断开了。手柄24上带有一个弧形延伸部703,其边缘上形成一个凸块704。该延伸部703以向使用者指示的形式带有标示器,在这种情况中是一些符号“开盖”、“压按钮”、“吸入”。当手柄24、以及延伸部703位于这些符号中的一个对应符号的特定位置时,可通过后壁702上的窗口705看到。延伸部703的终端构成一个按钮706。手柄远离延伸部703的端部带有一个与它一起枢转的舌片707。
图32在它的后部表示该装置。由窗口705可看见符号“开盖”。如果患者现在打开盖700,则使该装置处于图33所示的位置。可以看到,该盖子的顶部后缘已接触到凸块704并推动延伸部703转过一个角度,以便使符号“压按钮”可通过窗口705看到。如果此时使用者压按钮706则使手柄转动,由此打开含有粉剂的容器,如结合图1至3的描述的那样。这就使该装置处于图34所示的位置,其中通过窗口705可看到“吸入”的符号。在图34所示的位置还可以看到舌片707向上伸出。因此,当使用者在吸入药物后关闭该盖子时,舌片707被该盖下侧上的一个凸块708推动,从而推压手柄24和它的延伸部703,使其回到图32所示的位置,再次显示出符号“开盖”。
刚才所述的装置不仅对使用者给出了一步一步操作的指示,由此降低患者弄错的危险,而且对患者来说,不是按照确定的方式来使用该装置是困难的,因为实际上,一旦将按钮706压下就不能再次操作,除非使用者关闭该盖子并再次打开它。
在上述的一些实施例中,涉及一个接口件,但是,如果该装置不是用口吸入的,则可使用其它一些出口,例如接鼻件。

Claims (6)

1、一种用于吸入装置的药物包,该药物包包含一条由一片具有多个沿其长度间隔开设置的凹腔的基片和一片可剥开地气密封接在基片上以构成多个容器的密封盖片形成的长形带,每个容器内装有粉状的吸入药物。
2、如权利要求1所述的药物包,其特征在于:盖片可从基片的第一端沿纵向从该基片上剥开。
3、如权利要求1或2所述的药物包,其特征在于:该形长带具有足够的挠性以便被缠成一个卷。
4、如权利要求1或2所述的药物包,其特征在于:盖片和基片的前端部分没有相互封接在一起。
5、如权利要求4所述的药物包,其特征在于:所述的前端部分中的至少一个上设有能连接到一缠绕装置上的装置。
6、如权利要求1或2所述的药物包,其特征在于:在基片和盖片之间的气密封接遍及它们的整个宽度。
CN94116778A 1990-03-02 1994-09-29 用于吸入装置的药物包 Expired - Lifetime CN1066036C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9004781.2 1990-03-02
GB909004781A GB9004781D0 (en) 1990-03-02 1990-03-02 Device
OA60067A OA09393A (fr) 1990-03-02 1991-08-27 Dispositif d'inhalation.
APAP/P/1991/000321A AP310A (en) 1990-03-02 1991-08-30 Inhalation device.

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN91101342A Division CN1030491C (zh) 1990-03-02 1991-03-01 吸入装置

Publications (2)

Publication Number Publication Date
CN1107687A true CN1107687A (zh) 1995-09-06
CN1066036C CN1066036C (zh) 2001-05-23

Family

ID=33101575

Family Applications (2)

Application Number Title Priority Date Filing Date
CN91101342A Expired - Lifetime CN1030491C (zh) 1990-03-02 1991-03-01 吸入装置
CN94116778A Expired - Lifetime CN1066036C (zh) 1990-03-02 1994-09-29 用于吸入装置的药物包

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN91101342A Expired - Lifetime CN1030491C (zh) 1990-03-02 1991-03-01 吸入装置

Country Status (34)

Country Link
US (4) US5873360A (zh)
JP (1) JP3110477B2 (zh)
KR (1) KR100210412B1 (zh)
CN (2) CN1030491C (zh)
AP (1) AP310A (zh)
AT (1) AT401007B (zh)
AU (2) AU645056B2 (zh)
BE (1) BE1003798A4 (zh)
BR (1) BR9100843A (zh)
CA (1) CA2037421C (zh)
CH (1) CH683319A5 (zh)
CY (1) CY2010A (zh)
CZ (2) CZ285501B6 (zh)
DE (1) DE4106379C2 (zh)
DK (1) DK175075B1 (zh)
ES (1) ES2031763A6 (zh)
FI (2) FI107883B (zh)
FR (2) FR2659558B1 (zh)
GB (2) GB9004781D0 (zh)
GR (1) GR1002387B (zh)
HK (2) HK18895A (zh)
IE (1) IE64503B1 (zh)
IL (1) IL97396A (zh)
IT (1) IT1244655B (zh)
LU (1) LU87898A1 (zh)
NL (1) NL193930C (zh)
NO (3) NO302929B1 (zh)
NZ (1) NZ237274A (zh)
OA (1) OA09393A (zh)
PL (1) PL167736B1 (zh)
PT (1) PT96920B (zh)
RU (1) RU2075977C1 (zh)
SE (1) SE512934C2 (zh)
ZA (1) ZA911516B (zh)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101400398B (zh) * 2006-05-09 2012-01-18 季米特里奥斯·彭塔弗拉加斯 用于同时施予一种以上的药剂的干粉吸入装置
CN103252006A (zh) * 2007-07-06 2013-08-21 维克多瑞传送设备有限公司 吸入器
CN106139335A (zh) * 2015-04-09 2016-11-23 正大天晴药业集团股份有限公司 一种药粉释放装置

Families Citing this family (446)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909891D0 (en) * 1989-04-28 1989-06-14 Riker Laboratories Inc Device
UA26230A (uk) * 1990-03-02 1999-07-19 Глексо Груп Лімітед Іhгалятор для спільhого використаhhя з лікувальhим блоком і лікувальhий блок
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
SK280968B6 (sk) * 1990-03-02 2000-10-09 Glaxo Group Limited Balenie medikamentu na použite v inhalačnom prístroji
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
FR2667509B1 (fr) * 1990-10-04 1995-08-25 Valois Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
SK280014B6 (sk) * 1992-09-11 1999-07-12 Glaxo Group Limited Inhalátor
SE9203570D0 (sv) * 1992-11-27 1992-11-27 Astra Ab Inhaler for multiple use
JPH08504634A (ja) * 1992-12-24 1996-05-21 ローン−プーラン・ロレ・リミテツド 吸入装置
US5896855A (en) * 1992-12-24 1999-04-27 Rhone-Poulenc Rorer Limited Multi dose inhaler apparatus
GB9326574D0 (en) * 1993-12-31 1994-03-02 King S College London Dry power inhalers
JPH07219571A (ja) * 1994-01-31 1995-08-18 Yukihiko Takino カラオケ曲目表示装置
PT101450B (pt) * 1994-02-02 1999-11-30 Hovione Produtos Farmaceuticos Novo dispositivo para inalacao
GB9417399D0 (en) 1994-08-30 1994-10-19 Scherer Corp R P Ocular treatment device
ES2208980T3 (es) * 1994-08-30 2004-06-16 Pharmacia Ab Embalaje para dosis fluidas, dispositivo de tratamiento ocular y uso del mismo.
DE29501527U1 (de) * 1995-02-01 1995-03-30 Hugo Kern und Liebers GmbH & Co. Platinen- und Federnfabrik, 78713 Schramberg Vorrichtung zur Erzeugung inhalierbarer Wirkstoffpartikel
US5921237A (en) * 1995-04-24 1999-07-13 Dura Pharmaceuticals, Inc. Dry powder inhaler
US5622166A (en) * 1995-04-24 1997-04-22 Dura Pharmaceuticals, Inc. Dry powder inhaler delivery system
SE9503344D0 (sv) * 1995-09-27 1995-09-27 Astra Ab Inhalation device
JP2000503565A (ja) 1996-01-03 2000-03-28 グラクソ、グループ、リミテッド 吸入装置
US5857456A (en) * 1996-06-10 1999-01-12 Sarnoff Corporation Inhaler apparatus with an electronic means for enhanced release of dry powders
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
GB9626233D0 (en) * 1996-12-18 1997-02-05 Chawla Brinda P S Medicament packaging and deliveery device
SE9700424D0 (sv) * 1997-02-07 1997-02-07 Astra Ab Powder inhaler
US6006747A (en) * 1997-03-20 1999-12-28 Dura Pharmaceuticals, Inc. Dry powder inhaler
CA2212430A1 (en) 1997-08-07 1999-02-07 George Volgyesi Inhalation device
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
NZ504021A (en) * 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
US6116238A (en) * 1997-12-02 2000-09-12 Dura Pharmaceuticals, Inc. Dry powder inhaler
US7089935B1 (en) * 1999-01-22 2006-08-15 Glaxo Group Limited Inhalation device
GB9905538D0 (en) 1999-03-10 1999-05-05 Glaxo Group Ltd A device
US6601729B1 (en) 1999-03-26 2003-08-05 Papp Enterprises, Llc Automated portable medication radial dispensing apparatus and method using a carrier tape
GB9909354D0 (en) * 1999-04-24 1999-06-16 Glaxo Group Ltd Medicament carrier
GB9909357D0 (en) * 1999-04-24 1999-06-16 Glaxo Group Ltd Medicament carrier
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US6730066B1 (en) 1999-08-03 2004-05-04 Pharmacia Ab Liquid delivery container
GB9925934D0 (en) 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
US20010029947A1 (en) * 1999-12-17 2001-10-18 Steve Paboojian Receptacles to facilitate the extraction of powders
US7171965B2 (en) * 2000-02-01 2007-02-06 Valois S.A.S. Breath actuated dry powder inhaler and tape dose strip
GB0004456D0 (en) * 2000-02-26 2000-04-19 Glaxo Group Ltd Medicament dispenser
DE10011120A1 (de) * 2000-03-09 2001-09-13 Pfeiffer Erich Gmbh & Co Kg Spender für Medien
WO2001072605A1 (en) * 2000-03-27 2001-10-04 Dura Pharmaceuticals, Inc. Containers for individual doses of an inhalable pharmaceutical
WO2001085136A2 (en) * 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US20030003057A1 (en) * 2000-07-07 2003-01-02 Jeffry Weers Methods for administering leuprolide by inhalation
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
GB0012465D0 (en) * 2000-05-24 2000-07-12 Glaxo Group Ltd Monitoring method
GB0013619D0 (en) * 2000-06-06 2000-07-26 Glaxo Group Ltd Sample container
GB0014851D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Novel pharmaceutical formulation
GB0015034D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Inhalation device
TWI224512B (en) * 2000-06-23 2004-12-01 Norton Healthcare Ltd Reservoir pressure system for medicament inhaler
US7080644B2 (en) * 2000-06-28 2006-07-25 Microdose Technologies, Inc. Packaging and delivery of pharmaceuticals and drugs
EP1301230A1 (en) 2000-07-15 2003-04-16 Glaxo Group Limited Medicament dispenser
WO2002009674A2 (en) * 2000-07-28 2002-02-07 Inhale Therapeutic Systems, Inc. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
BRPI0113042B8 (pt) 2000-08-05 2021-05-25 Glaxo Group Ltd composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
WO2002013897A2 (en) 2000-08-14 2002-02-21 Advanced Inhalation Research, Inc. Inhalation device and method
AUPR020400A0 (en) * 2000-09-19 2000-10-12 Glaxo Wellcome Australia Ltd Inhalation device
GB0026647D0 (en) * 2000-10-31 2000-12-13 Glaxo Group Ltd Medicament dispenser
US20110301569A1 (en) 2001-01-20 2011-12-08 Gordon Wayne Dyer Methods and apparatus for the CVCS
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
DE10111945B4 (de) * 2001-03-13 2006-03-09 Alexander Christ Kapselspender
ES2296923T3 (es) 2001-03-22 2008-05-01 Glaxo Group Limited Derivados formanilidas como agonistas del adrenorreceptor beta2.
US6766799B2 (en) * 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
BR0209271A (pt) 2001-04-30 2004-06-15 Glaxo Group Ltd Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
US7766013B2 (en) * 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
FI20011317A0 (fi) 2001-06-20 2001-06-20 Orion Corp Jauheinhalaattori
JP2004537377A (ja) * 2001-08-09 2004-12-16 グラクソ グループ リミテッド 製薬組成物を有する吸入装置
USRE44874E1 (en) 2001-09-14 2014-04-29 Glaxo Group Limited Phenethanolamine derivatives for treatment of respiratory diseases
AU2002333644A1 (en) 2001-09-17 2003-04-01 Glaxo Group Limited Dry powder medicament formulations
CA2460904C (en) 2001-09-19 2011-03-22 Advent Pharmaceuticals Pty Ltd An inhaler for delivering metered doses of powdered medicament
GB0125135D0 (en) * 2001-10-19 2001-12-12 Glaxo Group Ltd Medicament dispenser
GB0125132D0 (en) * 2001-10-19 2001-12-12 Glaxo Group Ltd Medicament dispenser
GB0125134D0 (en) * 2001-10-19 2001-12-12 Glaxo Group Ltd Medicament dispenser
GB0127989D0 (en) * 2001-11-22 2002-01-16 Glaxo Group Ltd Medicament dispensing system
GB0130055D0 (en) * 2001-12-14 2002-02-06 Technology Innovation Ltd Medicament packaging
MXPA04005865A (es) * 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
GB0217199D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicament dispenser
GB0201677D0 (en) * 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
WO2003061744A1 (en) 2002-01-25 2003-07-31 Glaxo Group Limited Medicament dispenser
AU2003216401A1 (en) * 2002-03-01 2003-09-16 Glaxo Group Limited Rotary blending apparatus and system
EP1490031A1 (en) * 2002-03-07 2004-12-29 Vectura Limited Fast melt multiparticulate formulations for oral delivery
GB0205572D0 (en) * 2002-03-09 2002-04-24 Chawla Brinda P S Medicament delivery and packaging
WO2003095332A1 (en) * 2002-03-26 2003-11-20 Glaxo Group Limited A method for forming a laminate assembly and products formed thereby
GR1004350B (el) * 2002-03-29 2003-09-26 Συσκευη εισπνοων ξηρης σκονης
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
GB0208608D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Composition
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
AU2003222841A1 (en) 2002-04-25 2003-11-10 Glaxo Group Limited Phenethanolamine derivatives
JP2005524134A (ja) * 2002-04-25 2005-08-11 グラクソ グループ リミテッド 環境条件を検知するための磁気音響センサーシステムおよびそれに関連する方法
GB0209526D0 (en) * 2002-04-26 2002-06-05 Glaxo Group Ltd Medicament dispenser
GB0209528D0 (en) * 2002-04-26 2002-06-05 Glaxo Group Ltd Medicament dispenser
JP2005526261A (ja) * 2002-05-15 2005-09-02 グラクソ グループ リミテッド 医薬包装内の温度および水分プロファイルを測定するための微小電気機械システムおよび方法
GB0216831D0 (en) * 2002-07-19 2002-08-28 Glaxo Group Ltd Medicament dispenser
GB0217198D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicament dispenser
WO2004011067A1 (en) 2002-07-25 2004-02-05 Glaxo Group Limited Medicament dispenser
GB0217225D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
GB0217196D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicament dispenser
WO2004011068A1 (en) 2002-07-25 2004-02-05 Glaxo Group Limited Medicament dispenser
US20070139442A1 (en) * 2002-09-13 2007-06-21 Robinson Karl E Coated blending system
GB0221493D0 (en) * 2002-09-17 2002-10-23 Glaxo Group Ltd Method for loading a medicament dispenser with a medicament carrier
US6962266B2 (en) * 2002-10-04 2005-11-08 Ecolab Inc. Method and apparatus for using a unit dose dispenser
ES2291733T3 (es) * 2002-10-22 2008-03-01 Glaxo Group Limited Compuestos de ariletanolamina medicinales.
SI1556342T1 (sl) 2002-10-28 2008-08-31 Glaxo Group Ltd Fenetanolaminski derivat za zdravljenje respiratornih bolezni
WO2004060260A2 (en) * 2002-12-18 2004-07-22 Glaxo Group Limited Drug delivery system with vented mouthpiece
US20040173211A1 (en) * 2003-01-14 2004-09-09 Boehringer Ingelheim International Gmbh Powder inhaler
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
GB0303870D0 (en) * 2003-02-20 2003-03-26 Norton Healthcare Ltd Pre-metered dose magazine for breath-actuated dry powder inhaler
EP1603810B1 (en) * 2003-03-15 2010-08-11 Brin Tech International Limited Medicament package
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
TWI328009B (en) 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
GB0315509D0 (en) 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
GB0316335D0 (en) * 2003-07-11 2003-08-13 Glaxo Group Ltd Pharmaceutical formulations
PE20050250A1 (es) 2003-07-17 2005-04-08 Glaxo Group Ltd Antagonistas de los receptores muscarinicos de la acetilcolina
GB0317374D0 (en) * 2003-07-24 2003-08-27 Glaxo Group Ltd Medicament dispenser
PL1677795T3 (pl) 2003-10-14 2011-05-31 Glaxo Group Ltd Antagoniści receptora muskarynowego acetylocholiny
AP2006003575A0 (en) 2003-10-17 2006-04-30 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists.
GB2407042B (en) 2003-10-17 2007-10-24 Vectura Ltd Inhaler
GB0324654D0 (en) * 2003-10-22 2003-11-26 Glaxo Group Ltd Medicinal compounds
GB0324886D0 (en) * 2003-10-24 2003-11-26 Glaxo Group Ltd Medicinal compounds
GB0324897D0 (en) * 2003-10-24 2003-11-26 Glaxo Group Ltd Composition
WO2005044187A2 (en) * 2003-10-28 2005-05-19 Glaxo Group Limited Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
AR046225A1 (es) 2003-11-04 2005-11-30 Glaxo Group Ltd Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303570L (sv) 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
WO2005053647A1 (en) * 2003-12-03 2005-06-16 Microdrug Ag Medical product containing tiotropium
US7631812B2 (en) * 2003-12-10 2009-12-15 Williams Troy P Foldable transaction card systems
GB0329182D0 (en) 2003-12-17 2004-01-21 Glaxo Group Ltd Chemical compounds
CN101018580B (zh) * 2004-02-06 2010-07-14 微计量技术有限公司 与吸入装置一起使用的泡罩包装
GB2410947B (en) * 2004-02-11 2008-09-17 Cambridge Lab Ltd Pharmaceutical compounds
JP4825138B2 (ja) * 2004-02-16 2011-11-30 グラクソ グループ リミテッド 薬剤ディスペンサー用カウンター
EP1725236A4 (en) * 2004-03-11 2009-05-13 Glaxo Group Ltd NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS
US7384946B2 (en) 2004-03-17 2008-06-10 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
BRPI0509382A (pt) 2004-04-02 2007-09-18 Glaxo Group Ltd processo para a preparação de um sal monocloridrato de composto, monocloridrato cristalino, processo para obter monocloridrato cristalino, método para a profilaxia ou o tratamento de uma condição clìnica em um mamìfero, uso de monocloridrato cristalino, formulação farmacêutica, e, combinação
AU2004319427B2 (en) * 2004-04-24 2011-04-21 Inrange Systems, Inc. Integrated, non-sequential, remote medication management and compliance system
US7828147B2 (en) * 2004-04-24 2010-11-09 Inrange Systems, Inc. Multi-layer medication carrier
TWI363759B (en) 2004-04-27 2012-05-11 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
EP1747219A4 (en) 2004-05-13 2010-05-26 Glaxo Group Ltd Antagonists of muscarinic acetylcholine receptor
AR049384A1 (es) 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
PL1891974T3 (pl) 2004-05-31 2010-12-31 Almirall Sa Kombinacje zawierające środki przeciwmuskarynowe i inhibitory PDE4
ES2257152B1 (es) 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
SE530006C2 (sv) * 2004-06-18 2008-02-05 Mederio Ag Inhalator som använder balja
SE0401654D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab A support structure for a medicament
FR2872798B1 (fr) * 2004-07-09 2007-10-05 Valois Sas Ensemble de blisters pour dispositif d'inhalation
GB0418278D0 (en) * 2004-08-16 2004-09-15 Glaxo Group Ltd Medicament dispenser
EA200700743A1 (ru) * 2004-10-06 2007-10-26 Бёрингер Ингельхайм Интернациональ Гмбх Устройство для распыления порошка, устройство для хранения порошка и способ распыления порошка
EP1812778A2 (en) * 2004-11-12 2007-08-01 Glaxo Group Limited Sensor system with acoustic transducer
GB0427856D0 (en) * 2004-12-20 2005-01-19 Glaxo Group Ltd Maniflod for use in medicament dispenser
GB0427853D0 (en) * 2004-12-20 2005-01-19 Glaxo Group Ltd Manifold for use in medicament dispenser
GB0427858D0 (en) * 2004-12-20 2005-01-19 Glaxo Group Ltd Manifold for use in medicament dispenser
KR20070097106A (ko) * 2005-01-11 2007-10-02 글락소 그룹 리미티드 베타-2 아드레날린성 효능제의 신나메이트 염
FR2881111B1 (fr) * 2005-01-25 2010-07-30 Valois Sas Dispositif de distribution de produit fluide.
FR2881119B1 (fr) * 2005-01-25 2010-07-30 Valois Sas Dispositif de distribution de produit fluide.
FR2881118B1 (fr) * 2005-01-25 2007-04-20 Valois Sas Dispositif de distribution de produit fluide.
FR2881117B1 (fr) * 2005-01-25 2010-07-30 Valois Sas Dispositif de distribution de produit fluide.
CN104177448A (zh) 2005-02-10 2014-12-03 葛兰素集团有限公司 使用预分选技术制备乳糖的方法以及由此形成的药物制剂
WO2006086130A2 (en) * 2005-02-10 2006-08-17 Glaxo Group Limited Process for crystallizing lactose particles for use in pharmaceutical formulations
MY145281A (en) 2005-03-25 2012-01-13 Glaxo Group Ltd Novel compounds
AR053450A1 (es) 2005-03-25 2007-05-09 Glaxo Group Ltd Derivados de 3,4-dihidro-pirimido(4,5-d)pirimidin-2-(1h)-ona 1,5,7 trisustituidos como inhibidores de la quinasa p38
US20090042843A1 (en) * 2005-05-04 2009-02-12 Boehringer Ingelheim International Gmbh Inhalation Device Containing Plural Doses of a Pharmaceutical Composition
GB0509952D0 (en) * 2005-05-16 2005-06-22 Glaxo Group Ltd Fault indicator
ES2265276B1 (es) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
GB0514501D0 (en) * 2005-07-14 2005-08-24 Cambridge Lab Ireland Ltd Pharmaceutical compounds
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
DE102005035705A1 (de) 2005-07-27 2007-02-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arzneimittelblister
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
US20080234315A1 (en) * 2005-08-02 2008-09-25 Jakob Busch-Petersen M3 Muscarinic Acetylcholine Receptor Antagonists
WO2007016639A2 (en) * 2005-08-02 2007-02-08 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
GB0516168D0 (en) * 2005-08-05 2005-09-14 Cambridge Lab Ireland Ltd Pharmaceutical compounds
EP1937068A4 (en) 2005-08-18 2010-08-04 Glaxo Group Ltd ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
US20070068837A1 (en) * 2005-09-29 2007-03-29 D Angelis Bruno S Wound dressing dispenser
GB0521563D0 (en) 2005-10-21 2005-11-30 Glaxo Group Ltd Novel compounds
AR058289A1 (es) 2005-12-12 2008-01-30 Glaxo Group Ltd Colector para ser usado en dispensador de medicamento
AR058290A1 (es) * 2005-12-12 2008-01-30 Glaxo Group Ltd Dispensador de medicamento
AU2007210177C1 (en) 2006-01-31 2012-11-01 Oriel Therapeutics, Inc. Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
CN101437562A (zh) * 2006-03-03 2009-05-20 Stc.Unm公司 具有气动力弹性分散机构的干粉吸入器
US8127763B2 (en) * 2006-03-03 2012-03-06 Stc.Unm Dry powder inhaler with aeroelastic dispersion mechanism
GB0605150D0 (en) * 2006-03-14 2006-04-26 Glaxo Group Ltd Counter For Use With A Medicament Dispenser
EP1844808A1 (de) * 2006-04-13 2007-10-17 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Medikamenten-Ausgabevorrichtung
EP1844809A1 (de) * 2006-04-13 2007-10-17 Boehringer Ingelheim Pharma GmbH & Co. KG Medikamentenmagazin für einen Inhalator, sowie Mehrdosispulverinhalator
CA2649509A1 (en) 2006-04-20 2007-11-01 Glaxo Group Limited Novel compounds
GR1005620B (el) * 2006-05-09 2007-09-03 Βελτιωση συσκευης εισπνοων ξηρης σκονης
DE102006023662A1 (de) * 2006-05-18 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator
US9457161B2 (en) 2006-05-18 2016-10-04 Boehringer Ingelheim International Gmbh Inhaler
GB0611587D0 (en) 2006-06-12 2006-07-19 Glaxo Group Ltd Novel compounds
FR2904229B1 (fr) * 2006-07-25 2008-10-10 Valois Sas Dispositif de distribution de produit fluide.
JP2009545579A (ja) 2006-08-01 2009-12-24 グラクソ グループ リミテッド ピラゾロ[3,4−b]ピリジン化合物、及びpde4阻害薬としてのその使用
AU2007309412B2 (en) 2006-10-25 2011-10-20 Novartis Ag Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
GB0622827D0 (en) 2006-11-15 2006-12-27 Glaxo Group Ltd Sheet driver for use in a drug dispenser
EP1925295A1 (de) 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
US8225784B2 (en) * 2006-12-11 2012-07-24 Valois Sas Fluid product dispensing device
FR2909643B1 (fr) * 2006-12-11 2011-03-04 Valois Sas Dispositif de distribution de produit fluide
US20080163610A1 (en) * 2007-01-05 2008-07-10 Matthew Thomas Baird Method and system for regenerating exhaust system filtering and catalyst components using variable high engine idle
ES2306595B1 (es) 2007-02-09 2009-09-11 Laboratorios Almirall S.A. Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
ES2320955B1 (es) 2007-03-02 2010-03-16 Laboratorios Almirall S.A. Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
US8616199B2 (en) 2007-03-16 2013-12-31 Canon Kabushiki Kaisha Inhaler and ejection head unit attachable to the inhaler
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
JP5198801B2 (ja) * 2007-05-30 2013-05-15 株式会社吉野工業所 吸引式投薬器
WO2008156586A2 (en) * 2007-06-12 2008-12-24 Alkermes, Inc. Inhalation device for powdered substances
WO2009007068A1 (en) * 2007-07-06 2009-01-15 Boehringer Ingelheim International Gmbh Inhaler
EP2011536A1 (en) * 2007-07-06 2009-01-07 Boehringer Ingelheim Pharma GmbH & Co. KG Inhaler
ES2320961B1 (es) 2007-11-28 2010-03-17 Laboratorios Almirall, S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
JP2011507593A (ja) 2007-12-20 2011-03-10 アストラゼネカ・アクチエボラーグ 粉末854を脱凝集解体する装置ならびに方法
EP2244771A4 (en) * 2008-01-23 2013-11-06 Astrazeneca Ab MEDICINE-CONTAINING DISPENSER WITH AN INDICATION FOR DISPLAYING INFORMATION FOR A USER
EP2082759A1 (en) * 2008-01-24 2009-07-29 Boehringer Ingelheim International GmbH Inhaler
EP2082764A1 (en) * 2008-01-24 2009-07-29 Boehringer Ingelheim International GmbH Inhaler
EP2082758A1 (en) * 2008-01-24 2009-07-29 Boehringer Ingelheim International GmbH Inhaler
EP2096105A1 (en) 2008-02-28 2009-09-02 Laboratorios Almirall, S.A. Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2108641A1 (en) 2008-04-11 2009-10-14 Laboratorios Almirall, S.A. New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en) 2008-04-28 2009-11-04 Laboratorios Almirall, S.A. New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
GB0810857D0 (en) * 2008-06-13 2008-07-23 Cambridge Lab Ireland Ltd Pharmaceutical compounds
US8517009B2 (en) * 2008-07-13 2013-08-27 Map Pharmaceuticals, Inc. Methods and apparatus for delivering aerosolized medication
GB2462611A (en) * 2008-08-12 2010-02-17 Cambridge Lab Pharmaceutical composition comprising tetrabenazine
US20110053866A1 (en) * 2008-08-12 2011-03-03 Biovail Laboratories International (Barbados) S.R.L. Pharmaceutical compositions
GB2463451A (en) 2008-09-08 2010-03-17 Cambridge Lab 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
GB2463283A (en) * 2008-09-08 2010-03-10 Cambridge Lab 3,11b-cis-dihydrotetrabenazine for use in treating asthma
GB2463452A (en) * 2008-09-08 2010-03-17 Cambridge Lab Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
MX2011003244A (es) 2008-09-26 2011-04-28 Oriel Therapeutics Inc Inhaladores con discos de vias aereas con canales de vias aereas discretas y discos y metodos relacionados.
MX2011003233A (es) 2008-09-26 2011-04-28 Oriel Therapeutics Inc Inhaladores de polvo seco con miembros de perforacion doble y dispositivos y metodos relacionados.
CA2732826C (en) * 2008-09-26 2017-08-22 Oriel Therapeutics, Inc. Inhaler mechanisms with radially biased piercers and related methods
WO2010039201A2 (en) * 2008-09-30 2010-04-08 Oriel Therapeutics, Inc. Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
WO2010039202A2 (en) * 2008-10-01 2010-04-08 Oriel Therapeutics, Inc. Dry powder inhalers with rotating piercing mechanisms and related devices and methods
RU2514318C2 (ru) * 2008-10-08 2014-04-27 Астразенека Аб Ингалятор со звуковыми индикаторными средствами
GB201020130D0 (en) * 2010-11-26 2011-01-12 Vectura Delivery Devices Ltd Inhaler
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
EP2198908A1 (en) * 2008-12-19 2010-06-23 Boehringer Ingelheim International Gmbh Inhaler
UY32297A (es) 2008-12-22 2010-05-31 Almirall Sa Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
AU2010219097A1 (en) 2009-01-13 2011-08-04 Glaxo Group Limited Pyrimidinecarboxamide derivatives as inhibitors of SYK kinase
NZ574666A (en) * 2009-02-05 2009-04-30 Nexus6 Ltd A medicament inhaler holder that uses optical means to count and display the number of doses used
WO2010094643A1 (en) 2009-02-17 2010-08-26 Glaxo Group Limited Quinoline derivatives and their uses for rhinitis and urticaria
EP2221055A1 (en) 2009-02-18 2010-08-25 Almirall, S.A. 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function
EP2221297A1 (en) 2009-02-18 2010-08-25 Almirall, S.A. 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
PT3578169T (pt) 2009-02-26 2024-07-29 Glaxo Group Ltd Formulações farmacêuticas compreendendo 4-{(1r)-2-[(2,6- diclorobenzil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2- (hidroximetil)fenol
EP2226323A1 (en) 2009-02-27 2010-09-08 Almirall, S.A. New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
EP2228368A1 (en) 2009-03-12 2010-09-15 Almirall, S.A. Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
US8399436B2 (en) 2009-04-24 2013-03-19 Glaxo Group Limited N-pyrazolyl carboxamides as CRAC channel inhibitors
EP2421834A1 (en) 2009-04-24 2012-02-29 Glaxo Group Limited Pyrazole and triazole carboxamides as crac channel inhibitors
DE202009006141U1 (de) 2009-04-25 2009-08-27 Boehringer Ingelheim International Gmbh Inhalator
US9713575B2 (en) 2009-05-07 2017-07-25 Gea Process Engineering Limited Tablet production module and method for continuous production of tablets
US8985102B2 (en) * 2009-05-18 2015-03-24 Adamis Pharmaceuticals Corporation Dry powder inhalers
US8931479B2 (en) 2009-05-18 2015-01-13 Norton Healthcare Limited Dry-powder inhaler
WO2010133322A1 (en) 2009-05-18 2010-11-25 Norton Healthcare Limited Dry-powder inhaler
DK2432532T3 (da) 2009-05-18 2014-10-06 Norton Healthcare Ltd Tørpulverinhalator
WO2010135253A2 (en) 2009-05-18 2010-11-25 3M Innovative Properties Company Dry powder inhaler dose counters
MX2011012265A (es) * 2009-05-21 2012-04-11 Microdose Therapeutx Inc Sistema de casete rotatorio para inhalador de polvo seco.
US8985101B2 (en) 2009-05-21 2015-03-24 Microdose Therapeutx, Inc. Method and device for clamping a blister within a dry powder inhaler
AR077101A1 (es) 2009-06-16 2011-08-03 Schering Corp Esteroides de heteroarilo (3,2-c), como agonistas de receptor glucocorticoide, composiciones y usos de los mismos
EP2448623B1 (en) 2009-07-01 2017-12-20 AstraZeneca AB Dispenser and method for entraining powder in an airflow
GB0919431D0 (en) 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
GB0919432D0 (en) 2009-11-05 2009-12-23 Glaxosmithkline Llc Use
ES2654423T3 (es) 2009-11-05 2018-02-13 Glaxosmithkline Llc Inhibidor de bromodominio de benzodiacepina
WO2011054851A1 (en) 2009-11-05 2011-05-12 Glaxosmithkline Llc Novel process
GB0919434D0 (en) 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
GB0919423D0 (en) 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
HUE026421T2 (en) 2009-11-05 2016-05-30 Glaxosmithkline Llc Benzodiazepine Bromine Domain Inhibitor
GB0919426D0 (en) 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
EP2322176A1 (en) 2009-11-11 2011-05-18 Almirall, S.A. New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
AU2010319328A1 (en) 2009-11-12 2012-05-31 Stc.Unm Dry powder inhaler with flutter dispersion member
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
TR200909791A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Salmeterol ve flutikazon içeren farmasötik bileşim@
EP3431128A1 (en) 2010-01-05 2019-01-23 MicroDose Therapeutx, Inc. Inhalation device and method
US8490795B2 (en) 2010-02-01 2013-07-23 Mallinckrodt Llc Container and method for facilitating disposal of unused pharmaceutical product
US9046403B2 (en) * 2010-02-01 2015-06-02 Mallinckrodt Llc Systems and methods for managing use of a medicament
JP2013523375A (ja) * 2010-04-13 2013-06-17 ビルギチ,マフムト 乾燥粉末吸入器のマウスピースボタン
EP2380890A1 (en) 2010-04-23 2011-10-26 Almirall, S.A. New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
GB201007203D0 (en) 2010-04-29 2010-06-16 Glaxo Group Ltd Novel compounds
EP2386555A1 (en) 2010-05-13 2011-11-16 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
EP2394998A1 (en) 2010-05-31 2011-12-14 Almirall, S.A. 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
FR2961186B1 (fr) * 2010-06-11 2012-07-13 Valois Sas Dispositif de distribution de produit fluide.
ES2526671T3 (es) 2010-06-22 2015-01-14 Glaxosmithkline Llc Compuestos de benzotriazoldiazepina inhibidores de bromodominios
FR2962345B1 (fr) 2010-07-09 2013-06-21 Valois Sas Inhalateur unidose de poudre seche pour blister pelable.
CN103118727B (zh) * 2010-07-21 2015-11-25 阿斯利康(瑞典)有限公司 吸入器
WO2012025473A1 (en) 2010-08-24 2012-03-01 Glaxo Group Limited Cc.chemokine receptor 4 antagonists
WO2012025474A1 (en) 2010-08-24 2012-03-01 Glaxo Group Limited Indazole compounds
JP5792308B2 (ja) 2010-08-31 2015-10-07 グラクソ グループ リミテッドGlaxo Group Limited 水分制御特性を示す乾燥粉末吸入薬物製品及びその投与方法
JP5792307B2 (ja) 2010-08-31 2015-10-07 グラクソ グループ リミテッドGlaxo Group Limited 水分制御特性を示す乾燥粉末吸入薬物製品及びその投与方法
EP2441755A1 (en) 2010-09-30 2012-04-18 Almirall, S.A. Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
ES2532213T3 (es) 2010-10-21 2015-03-25 Glaxo Group Limited Compuestos de pirazol que actúan contra afecciones alérgicas, inmunitarias e inflamatorias
JP2013544794A (ja) 2010-10-21 2013-12-19 グラクソ グループ リミテッド アレルギー性障害、炎症性障害及び免疫障害に作用するピラゾール化合物
WO2012064286A1 (en) 2010-11-11 2012-05-18 Agency For Science, Technology And Research Targeting metabolic enzymes in human cancer
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
EP2463289A1 (en) 2010-11-26 2012-06-13 Almirall, S.A. Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
WO2012078804A1 (en) 2010-12-07 2012-06-14 Respira Therapeutics, Inc. Dry powder inhaler
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors
JP2014507458A (ja) 2011-03-11 2014-03-27 グラクソ グループ リミテッド Sykインヒビターとしてのピリド[3,4−B]ピラジン誘導体
GB201104153D0 (en) 2011-03-11 2011-04-27 Glaxo Group Ltd Novel compounds
US8834411B2 (en) 2011-04-06 2014-09-16 Mystic Pharmaceuticals, Inc. Medical devices for dispensing powders
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
GB201106799D0 (en) 2011-04-21 2011-06-01 Glaxosmithkline Llc Novel compounds
GB201106743D0 (en) 2011-04-21 2011-06-01 Glaxosmithkline Llc Novel compounds
GB201106750D0 (en) 2011-04-21 2011-06-01 Glaxosmithkline Llc Novel compounds
EP2518070A1 (en) 2011-04-29 2012-10-31 Almirall, S.A. Pyrrolotriazinone derivatives as PI3K inhibitors
EP2518071A1 (en) 2011-04-29 2012-10-31 Almirall, S.A. Imidazopyridine derivatives as PI3K inhibitors
GB201107325D0 (en) 2011-05-04 2011-06-15 Glaxosmithkline Llc Novel compounds
EP2526945A1 (en) 2011-05-25 2012-11-28 Almirall, S.A. New CRTH2 Antagonists
EP2527344A1 (en) 2011-05-25 2012-11-28 Almirall, S.A. Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
MX2013014399A (es) 2011-06-08 2014-03-21 Glaxo Group Ltd Combinacion que comprende umeclidinio y un corticosteroide.
RU2013153202A (ru) 2011-06-08 2015-07-20 Глаксо Груп Лимитед Композиции для ингалятора сухого порошка, содержащие умеклидиний
EP2548876A1 (en) 2011-07-18 2013-01-23 Almirall, S.A. New CRTh2 antagonists
EP2548863A1 (en) 2011-07-18 2013-01-23 Almirall, S.A. New CRTh2 antagonists.
EP2554544A1 (en) 2011-08-01 2013-02-06 Almirall, S.A. Pyridin-2(1h)-one derivatives as jak inhibitors
GB201114103D0 (en) 2011-08-17 2011-09-28 Glaxosmithkline Llc Novel compounds
GB201116641D0 (en) 2011-09-27 2011-11-09 Glaxo Group Ltd Novel compounds
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2592077A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
EP2592078A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
US9603906B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Inhalable liquid formulations of DNase I
GB2499597A (en) * 2012-02-21 2013-08-28 Innovata Biomed Ltd Dry powder inhaler with stepped rotation of metering member
US10463815B2 (en) 2012-02-21 2019-11-05 Respira Therapeutics, Inc. Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
EP2647627A1 (en) 2012-04-02 2013-10-09 Almirall, S.A. Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one.
DE102012104850A1 (de) 2012-04-05 2013-10-10 Alfred Von Schuckmann Vorrichtung zur portionierten Ausgabe von Medikamenten
EP2836204B1 (en) 2012-04-13 2020-07-08 GlaxoSmithKline Intellectual Property Development Limited Aggregate particles
GB201207406D0 (en) 2012-04-27 2012-06-13 Glaxo Group Ltd Novel compounds
PE20142400A1 (es) 2012-04-27 2015-02-04 Glaxo Group Ltd Compuestos novedosos
EP2662105B1 (de) 2012-05-09 2017-01-18 Boehringer Ingelheim International GmbH Zerstäuber
FR2990872B1 (fr) 2012-05-24 2015-05-15 Valois Sas Dispositif de distribution de produit fluide.
EP2666465A1 (en) 2012-05-25 2013-11-27 Almirall, S.A. Novel dosage and formulation
GB2502350A (en) 2012-05-25 2013-11-27 Vectura Delivery Devices Ltd Inhaler having means to control the force applied to an actuating lever
EA201492044A1 (ru) * 2012-05-25 2015-05-29 Арвен Айлак Санайи Ве Тиджарет А.С. Ингалятор, содержащий внутренний корпус, имеющий канал для воздуха
WO2013176639A1 (en) * 2012-05-25 2013-11-28 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhaler device with an improved blister advancement mechanism
EP2668941A1 (en) 2012-05-31 2013-12-04 Almirall, S.A. Novel dosage form and formulation of abediterol
SG11201408411VA (en) * 2012-07-05 2015-01-29 Glaxo Group Ltd Inhaler device
WO2014060431A1 (en) 2012-10-16 2014-04-24 Almirall, S.A. Pyrrolotriazinone derivatives as pi3k inhibitors
EP2738172A1 (en) 2012-11-28 2014-06-04 Almirall, S.A. New bicyclic compounds as crac channel modulators
SG11201503697TA (en) 2012-11-28 2015-06-29 Intercept Pharmaceuticals Inc Treatment of pulmonary disease
JP5350530B1 (ja) * 2012-12-07 2013-11-27 ニップファーマ株式会社 薬剤吸入デバイス
MA38260B1 (fr) 2012-12-18 2018-04-30 Almirall Sa Nouveaux dérivés de cyclohexyl et quinuclidinyl carbamate ayant une activité d'agoniste adrénergique beta2 et une activité d'antagoniste muscarinique m3
UY35332A (es) 2013-02-15 2014-11-28 Almirall Sa Derivados de pirrolotriazina como inhibidores de pi3k
US9637456B2 (en) 2013-03-14 2017-05-02 Glaxosmithkline Intellectual Property (No. 2) Limited 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
JP6280573B2 (ja) 2013-03-14 2018-02-14 グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited ブロモドメイン阻害薬としてのフロピリジン
GB201305668D0 (en) 2013-03-28 2013-05-15 Glaxosmithkline Ip Dev Ltd Avs6 Integrin Antagonists
JP6105373B2 (ja) * 2013-04-25 2017-03-29 株式会社吉野工業所 吸引器具
JP5985434B2 (ja) * 2013-04-25 2016-09-06 株式会社吉野工業所 吸引器具
RU2544801C2 (ru) * 2013-06-11 2015-03-20 Открытое Акционерное Общество "Фармацевтическая Фабрика Санкт-Петербурга" Порошковый ингалятор
EP2848615A1 (en) 2013-07-03 2015-03-18 Almirall, S.A. New pyrazole derivatives as CRAC channel modulators
USD737425S1 (en) 2013-07-09 2015-08-25 Celon Pharma S.A. Inhaler
USD746378S1 (en) 2013-07-30 2015-12-29 Celon Pharma S.A. Label for an inhaler
USD759163S1 (en) 2013-07-30 2016-06-14 Celon Pharma S.A. Label for an inhaler
CN103624401B (zh) * 2013-08-20 2016-03-02 南京理工大学 立式定量控制的自动爆炸复合炸药铺放装置
WO2015091285A1 (en) 2013-12-19 2015-06-25 Almirall S.A. Dosage formulation comprising salmeterol and fluticasone propionate
WO2015097662A1 (en) 2013-12-23 2015-07-02 Glenmark Pharmaceuticals Ltd A dry powder inhaler
EA201692111A1 (ru) 2014-05-12 2017-08-31 Глаксосмитклайн Интеллекчуал Проперти (№ 2) Лимитед Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
EP4252742A3 (en) 2014-05-28 2023-12-27 GlaxoSmithKline Intellectual Property Development Ltd Fluticasone furoate in the treatment of copd
EP2957552B1 (en) 2014-06-16 2020-01-22 Arven Ilac Sanayi Ve Ticaret A.S. Vilanterol formulations
MA39288A (fr) 2014-06-16 2015-12-23 Arven Ilac Sanayi Ve Ticaret As Formulations pharmaceutiques comprenant du vilanterol
TR201407010A2 (tr) 2014-06-16 2015-12-21 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Vilanterol formülasyonları.
EP2957553A1 (en) 2014-06-16 2015-12-23 Arven Ilac Sanayi Ve Ticaret A.S. Pharmaceutical formulations of vilanterol
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide
US9550032B2 (en) * 2014-10-12 2017-01-24 Kendra Baldwin Wearable wrist inhaler
EP3212212B1 (en) 2014-10-31 2020-09-23 Monash University Powder formulation
MX2017009112A (es) 2015-01-14 2018-06-15 Respira Therapeutics Inc Metodos y dispositivos de dispersion de polvo.
GB201503720D0 (en) 2015-03-05 2015-04-22 Glaxosmithkline Ip No 2 Ltd Chemical compound
TW201643179A (zh) 2015-03-11 2016-12-16 葛蘭素史克智慧財產發展有限公司 Tslp結合蛋白
USD767114S1 (en) 2015-03-18 2016-09-20 Amneal Pharmaceuticals Company Gmbh Inhalation device
USD769439S1 (en) 2015-03-18 2016-10-18 Amneal Pharmaceuticals Company Gmbh Inhalation device
GB201504689D0 (en) 2015-03-19 2015-05-06 Glaxosmithkline Ip Dev Ltd Chemical compounds
WO2016161830A1 (zh) * 2015-04-09 2016-10-13 正大天晴药业集团股份有限公司 药物释放带
TWI597079B (zh) * 2015-04-10 2017-09-01 微劑量醫療公司 泡殼帶進給機構
US10214509B2 (en) 2015-04-21 2019-02-26 Almirall, S.A. Amino-substituted heterocyclic derivatives as sodium channel inhibitors
AU364719S (en) 2015-05-20 2015-10-14 Korea United Pharm Inc Medicine inhaler
CA2988374A1 (en) 2015-06-15 2016-12-22 Glaxosmithkline Intellectual Property Development Limited Nrf2 regulators
MX2017016405A (es) 2015-06-15 2018-05-22 Glaxosmithkline Ip Dev Ltd Reguladores de nrf2.
CA2988373A1 (en) 2015-06-15 2016-12-22 Glaxosmithkline Intellectual Property Development Limited Nrf2 regulators
WO2016202800A1 (en) 2015-06-16 2016-12-22 Almirall, S.A. Pyrrolotriazinone derivatives as pi3k inhibitors
CN107614037B (zh) * 2015-07-29 2021-09-03 正大天晴药业集团股份有限公司 药物释放带
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
EP3353162A1 (en) 2015-09-22 2018-08-01 Glaxosmithkline Intellectual Property (No. 2) Limited Pyridinone dicarboxamide for use as bromodomain inhibitors
WO2017060854A1 (en) 2015-10-06 2017-04-13 Glaxosmithkline Intellectual Property Development Limited Biaryl pyrazoles as nrf2 regulators
EP3371167A1 (en) 2015-10-06 2018-09-12 GlaxoSmithKline Intellectual Property Development Limited Arylcyclohexyl pyrazoles as nrf2 regulators
JP2018535984A (ja) 2015-11-18 2018-12-06 グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited リバビリンの医薬組成物
GB201604680D0 (en) 2016-03-21 2016-05-04 Glaxosmithkline Ip Dev Ltd Chemical Compounds
CA3018275A1 (en) 2016-04-07 2017-10-12 Glaxosmithkline Intellectual Property (No.2) Limited Benzo[b]furans as bromodomain inhibitors
AU2017245641A1 (en) 2016-04-07 2018-09-13 Glaxosmithkline Intellectual Property (No.2) Limited Pyridyl derivatives as bromodomain inhibitors
WO2017176291A1 (en) * 2016-04-08 2017-10-12 Kendra Baldwin T Wearable wrist inhaler
JP6885968B2 (ja) 2016-05-24 2021-06-16 グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited ブロモドメイン阻害薬としてのピリジンジカルボキサミド誘導体
GB201614934D0 (en) 2016-09-02 2016-10-19 Glaxosmithkline Intellectual Property (No 2) Ltd Chemical compounds
GB201614939D0 (en) 2016-09-02 2016-10-19 Glaxosmithkline Ip Dev Ltd Crystalline hydrate
GB201614940D0 (en) 2016-09-02 2016-10-19 Glaxosmithkline Intellectual Property (No 2) Ltd Chemical compounds
CA3036933A1 (en) 2016-09-20 2018-03-29 Glaxosmithkline Intellectual Property (No.2) Limited Trpv4 antagonists
TW201825458A (zh) 2016-09-20 2018-07-16 英商葛蘭素史克智慧財產(第二)有限公司 Trpv4拮抗劑
WO2018055527A1 (en) 2016-09-20 2018-03-29 Glaxosmithkline Intellectual Property (No.2) Limited Trpv4 antagonists
CN109045427B (zh) * 2016-10-03 2021-06-25 捷普科技(上海)有限公司 药剂分配器
US20190307975A1 (en) 2016-11-21 2019-10-10 Lupin Inc. Medicament dispenser
CN108779108A (zh) 2016-12-06 2018-11-09 葛兰素史密斯克莱知识产权发展有限公司 3-(2,3-二氢-1h-茚-5-基)丙酸衍生物和它们作为nrf2调节剂的用途
JP2020500918A (ja) 2016-12-12 2020-01-16 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited Nrf2レギュレーターとしてのn−アリールピラゾール
WO2018109641A1 (en) 2016-12-12 2018-06-21 Glaxosmithkline Intellectual Property Development Limited 3-carboxylic acid pyrroles as nrf2 regulators
US11117905B2 (en) 2016-12-14 2021-09-14 Glaxosmithkline Intellectual Property Development Limited Bisaryl heterocycles as NRF2 activators
US20220002272A1 (en) 2016-12-14 2022-01-06 Glaxosmithkline Intellectual Property Development Limited Bisaryl lactams as nrf2 activators
US11078216B2 (en) 2016-12-14 2021-08-03 Glaxosmithkline Intellectual Property Development Limited Bisaryl amides as NRF2 activators
JP7110197B2 (ja) 2016-12-15 2022-08-01 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド Nrf2アクチベーター
JP2020502152A (ja) 2016-12-15 2020-01-23 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited Nrf2アクチベーターとしてのエーテル結合トリアゾール
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
GB201703282D0 (en) 2017-03-01 2017-04-12 Glaxosmithkline Intellectual Property (No 2) Ltd Compounds
CN108622469B (zh) * 2017-03-24 2023-08-15 李和伟 一种独立包装的履带式给药器
US11167022B2 (en) 2017-03-31 2021-11-09 Glaxosmithkline Intellectual Property Development Limited Immunogenic composition, use and method of treatment
US11014941B2 (en) 2017-04-24 2021-05-25 Cocrystal Pharma, Inc. Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
ES2932836T3 (es) 2017-07-25 2023-01-26 Adherium Nz Ltd Procedimiento y dispositivo de control de la adherencia
TW201919682A (zh) 2017-08-08 2019-06-01 西班牙商阿爾米雷爾有限公司 活化Nrf2路徑的新穎化合物
GB201716369D0 (en) 2017-10-06 2017-11-22 Glaxosmithkline Intellectual Property (No 2) Ltd Compounds
GB201716392D0 (en) 2017-10-06 2017-11-22 Glaxosmithkline Intellectual Property (No 2) Ltd Compounds
WO2019116231A1 (en) 2017-12-11 2019-06-20 Glaxosmithkline Intellectual Property Development Limited Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
US20210177861A1 (en) 2017-12-11 2021-06-17 Glaxosmithkline Intellectual Property Development Limited Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
GB201720989D0 (en) 2017-12-15 2018-01-31 Glaxosmithkline Ip Dev Ltd Chemical compounds
CA3088347A1 (en) 2018-01-17 2019-07-25 Glaxosmithkline Intellectual Property Development Limited Pi4kiii.beta. inhibitors
CN110237373B (zh) * 2018-03-08 2023-06-02 润生药业有限公司 一种生产用于联合用药的药物载体的装置及方法
US20210085897A1 (en) 2018-04-06 2021-03-25 Lupin Inc. Medicament dispenser
WO2019224667A1 (en) 2018-05-23 2019-11-28 Glaxosmithkline Intellectual Property Development Limited Indanes as nrf2 activators
MX2021000917A (es) 2018-07-27 2021-06-23 Cocrystal Pharma Inc Derivados de pirrolo[2,3-b]piridina como inhibidores de la replicación del virus de la gripe.
GB201812671D0 (en) 2018-08-03 2018-09-19 Coalesce Product Dev Ltd An inhaler device
GB201814167D0 (en) 2018-08-31 2018-10-17 Glaxosmithkline Ip No 2 Ltd Compounds
CN113286793B (zh) 2018-09-10 2024-04-05 共结晶制药公司 吡咯并吡嗪和吡啶并三嗪类流感病毒复制抑制剂
CA3112309C (en) 2018-09-10 2024-06-04 Cipla Limited Single blister-strip based dispenser
MX2021004215A (es) 2018-10-17 2021-07-15 Cocrystal Pharma Inc Combinaciones de inhibidores de la replicación del virus de la gripe.
EA202191327A1 (ru) 2018-11-13 2021-08-09 Кокристал Фарма, Инк. Лекарственные формы терапевтических препаратов от гриппа
EP3887355A1 (en) 2018-11-26 2021-10-06 Cocrystal Pharma, Inc. Inhibitors of influenza virus replication
BR112021021775A2 (pt) 2019-04-29 2022-01-04 Insmed Inc Composições de pó seco de pró-fármacos de treprostinil e métodos de uso destas
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia
GB201908536D0 (en) 2019-06-13 2019-07-31 Glaxosmithkline Ip Dev Ltd Compounds
EP4114743A1 (en) 2020-03-06 2023-01-11 Vectura Delivery Devices Limited Process for manufacturing a blister strip for a dry powder inhaler
WO2021188620A1 (en) 2020-03-17 2021-09-23 Cocrystal Pharma Inc. Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
CA3176877A1 (en) 2020-03-25 2021-09-30 Lupin Inc. Multi-carrier medicament dispensers
KR20230008079A (ko) 2020-04-10 2023-01-13 코크리스탈 파마, 아이엔씨. 노로바이러스 및 코로나바이러스 복제 억제제
EP4138884A1 (en) 2020-04-20 2023-03-01 Sorrento Therapeutics, Inc. Pulmonary administration of ace2 polypeptides
EP4061457A1 (en) 2020-06-15 2022-09-28 Norton (Waterford) Limited Blister pack and inhaler comprising the same
PL244221B1 (pl) 2020-09-24 2023-12-18 Polfarmex Spolka Akcyjna Inhalator do podawania leku
PL244222B1 (pl) 2020-09-24 2023-12-18 Polfarmex Spolka Akcyjna Inhalator do podawania leku
WO2022175423A1 (en) 2021-02-22 2022-08-25 Glaxosmithkline Biologicals Sa Immunogenic composition, use and methods
WO2022175425A1 (en) 2021-02-22 2022-08-25 Glaxosmithkline Intellectual Property Development Limited Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
WO2022179967A1 (en) 2021-02-23 2022-09-01 Glaxosmithkline Intellectual Property (No.2) Limited Vadadustat for treating covid-19 in a hospitalized subject
CA3227602A1 (en) 2021-08-03 2023-02-09 Irina C. Jacobson Inhibitors for coronaviruses
GB202111658D0 (en) 2021-08-13 2021-09-29 Norton Waterford Ltd Dry powder medicament inhaler
EP4331647A3 (en) 2021-08-13 2024-05-29 Norton (Waterford) Limited Dry powder medicament inhaler
WO2023052477A1 (en) 2021-09-29 2023-04-06 Norton (Waterford) Limited Dry powder medicament inhaler
AU2022354108A1 (en) 2021-09-29 2024-03-28 Norton (Waterford) Limited Dry powder medicament inhaler
GB202113921D0 (en) 2021-09-29 2021-11-10 Norton Waterford Ltd Dry powder medicament inhaler
CN114178071B (zh) * 2021-12-10 2022-09-09 杭州博乐工业设计股份有限公司 一种可更换储液设备的喷雾器
WO2023150747A1 (en) 2022-02-07 2023-08-10 Insmed Incorporated Dry powder compositions of bedaquiline and salts and methods of use thereof
GB2618145A (en) * 2022-04-29 2023-11-01 Merxin Ltd Manifold

Family Cites Families (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB190013597A (en) * 1900-07-28 1901-06-01 Kodak Ltd Improvements in or relating to Spools applicable for Photographic Films.
GB190019108A (en) * 1900-10-25 1901-08-10 Kodak Ltd Improvements in or relating to Photographic Film Cartridges and the like.
GB190210766A (en) * 1902-05-10 1903-03-19 Kodak Ltd Improvements in Film Spools and in their Connections with Photographic Cameras
GB190303282A (en) * 1903-02-11 1903-12-17 Kodak Ltd Improvements in or relating to Photographic Film Cartridges.
US1183848A (en) * 1913-07-02 1916-05-23 Charles M Herring Pin-holder.
US1339503A (en) * 1918-01-19 1920-05-11 Denjamin S Elrod Pin-dispenser
DE333415C (de) * 1919-04-09 1921-02-24 Eagle Engineering Company Ltd Bodenbearbeitungsgeraet
US1405357A (en) * 1921-05-07 1922-01-31 Leverett W Tiffany Dispensing device
GB372397A (en) * 1931-02-07 1932-05-09 Kodak Ltd Improvements in or relating to roll film cameras and a method of manipulating films therein
GB430536A (en) * 1933-06-15 1935-06-20 Voigtlaender & Sohn Ag Photographic film cameras
GB522826A (en) * 1937-12-24 1940-06-27 Kodak Ltd Improvements in or relating to automatic photographic film winding mechanism
GB557061A (en) * 1942-02-13 1943-11-02 Kodak Ltd Improvements in or relating to photographic film apparatus such as a camera or optical projection apparatus
GB558515A (en) * 1942-02-13 1944-01-07 Kodak Ltd Improvements in or relating to photographic apparatus employing roll film
GB664223A (en) * 1948-10-19 1952-01-02 Kodak Ltd Improvements in or relating to apparatus using photographic roll-film
GB716109A (en) * 1950-06-22 1954-09-29 Crosweller & Co Ltd W Improvements in, or relating to, apparatus for winding paper, or other similar flexible strip material, into roll form
GB708506A (en) * 1951-10-20 1954-05-05 Kodak Ltd Improvements in or relating to film feeding apparatus
US2771214A (en) * 1953-09-14 1956-11-20 Ivers Lee Co Dispensing carton for package strips
BE537510A (zh) * 1954-04-26
CH385718A (fr) * 1961-11-04 1964-12-15 Bodet Jean Procédé et dispositif pour conditionner des articles solides de petit volume, et ensemble obtenu par ce procédé
CH406058A (de) * 1962-08-14 1966-01-15 Marcus Dr Diamant Bandförmige Verpackung zur portionsweisen Freigabe von festen, pulverförmigen oder flüssigen Produkten
DE1461280A1 (de) * 1963-07-11 1969-02-27 Zimmermann & Co Mehrschichtblaetter aus Papier od.dgl.mit Hohlraeumen zur Aufnahme von vorzugsweise pulverfoermigen Stoffen und Verfahren zur Herstellung solcher Mehrschichtblaetter
US3380578A (en) * 1964-03-04 1968-04-30 George C. Sparks Strip package assembly
DE1220724B (de) * 1964-04-29 1966-07-07 Kodak Ag Photographische oder kinematographische Aufnahme- und Wiedergabegeraete mit einer Vorrichtung zum Einlegen von Filmen oder Baendern
DE1288905B (de) * 1964-07-27 1969-02-06 Canon Camera Co Kamera mit einer Filmaufwicklungsvorrichtung
DE1232458B (de) * 1964-08-27 1967-01-12 Kodak Ag Photographische Kamera
DE1253573B (de) * 1965-09-11 1967-11-02 Kodak Ag Photographische Kamera
US3482733A (en) * 1965-10-01 1969-12-09 Robert C Groves Strip package
GB1105816A (en) * 1965-10-20 1968-03-13 Certo Camera Werk Von Der Gonn Improvements in photographic cameras
US3367535A (en) * 1966-11-16 1968-02-06 Tanguay William Gilman Pill dispenser
US3362578A (en) * 1966-12-21 1968-01-09 Robins Co Inc A H Tamper-proof strip table dispenser
US3410450A (en) * 1967-06-16 1968-11-12 Jerry A. Fortenberry Sanitary pill dispenser with indicator
US3454194A (en) * 1968-03-25 1969-07-08 Sidney S Becker Safety tablet dispenser
IT941426B (it) * 1971-07-17 1973-03-01 Isf Spa Inalatore a camera di turbinio per sostanze medicamentose polveriformi
GB1387954A (en) * 1973-05-08 1975-03-19 Miles Lab Insufflator
GB1479283A (en) * 1973-07-23 1977-07-13 Bespak Industries Ltd Inhaler for powdered medicament
US3964638A (en) * 1974-12-19 1976-06-22 Dimauro Frank S Dispenser for bodies in sealed sheet material compartments
GB1518998A (en) * 1975-08-28 1978-07-26 Gillette Co Packaging flowable materials
DD139770A1 (de) * 1978-03-01 1980-01-16 Werner Hahn VERFAHREN ZUM FILMTRANSPORT IN FOTOGRAFISCHEN KAMER&S
DE2837040C2 (de) * 1978-08-24 1982-10-21 Siemens AG, 1000 Berlin und 8000 München Flüssigkeitstransportsystem für ein Inhalationsgerät
EP0009538A1 (de) * 1978-08-31 1980-04-16 Peter Dzsida Vorrichtung zum Ausdrücken von Körpern aus Blisterpackungstafeln
IT7920688V0 (it) * 1979-02-05 1979-02-05 Chiesi Paolo Parma Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore.
US4243144A (en) * 1979-04-09 1981-01-06 Sterling Drug Inc. Bend and peel blister strip package
AU545574B2 (en) * 1979-10-30 1985-07-18 Riker Laboratories, Inc. Breath actuated devices for adminstering powdered medicaments
GB2067155B (en) * 1979-12-03 1983-12-21 Davies L Apparatus for ejecting contents of buster packs
US4303325A (en) * 1980-10-10 1981-12-01 Eastman Kodak Company Roll film and a photographic camera for use therewith
DE3260483D1 (de) * 1981-03-03 1984-09-06 Wellcome Found Deblistering machine
US4332453A (en) * 1981-05-06 1982-06-01 Eastman Kodak Company Film loading apparatus
DE3120864C1 (de) * 1981-05-26 1982-10-28 Agfa-Gevaert Ag, 5090 Leverkusen Fotografische Rollfilmkamera mit einer spulenlosen Aufwickelkammer und in letzterer vorgesehenen Filmwickelbildungsmitteln
NL8103573A (nl) * 1981-07-29 1983-02-16 Philips Nv Inrichting voor het tegelijkertijd toevoeren van meerdere in banden verpakte electrische en/of electronische onderdelen aan een bepaalde positie.
NL8103574A (nl) * 1981-07-29 1983-02-16 Philips Nv Werkwijze en inrichting voor het plaatsen van elektrische en/of elektronische onderdelen op een substraat.
FR2516387A1 (fr) * 1981-11-16 1983-05-20 Fabre Sa Pierre Inhalateur liberant des quantites pre-dosees de principe actif volatil ou entrainable par un excipient volatil contenu dans des microcapsules reparties periodiquement sur un support, ainsi que ledit support et son procede de fabrication
US4444310A (en) * 1982-07-26 1984-04-24 Becton, Dickinson And Company Segmented multi-product package assembly
GB2169265B (en) * 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
FI79651C (fi) * 1982-10-08 1990-02-12 Glaxo Group Ltd Doseringsanordning foer medicin.
FR2538792B1 (fr) * 1982-12-29 1985-07-12 Merck Sharp & Dohme Emballage distributeur pour doses individuelles conditionnees sous coque, notamment pour doses therapeutiques
EP0118179A1 (en) * 1983-02-09 1984-09-12 The Wiggins Teape Group Limited Blister pack
US4525048A (en) * 1983-03-21 1985-06-25 W. Haking Enterprises, Limited Automatic slot positioning device for camera take-up spool
US4488796A (en) * 1983-04-25 1984-12-18 Edwards Evan A Photographic still camera film system
NL8303816A (nl) * 1983-11-05 1985-06-03 Philips Nv Inrichting voor het toevoeren van in band verpakte electronische onderdelen naar een opneempositie.
GB8314308D0 (en) * 1983-05-24 1983-06-29 Matburn Holdings Ltd Medical administration devices
US4604847A (en) * 1983-09-14 1986-08-12 Moulding Jr Thomas S Medicine package, method of opening the package, and machine for performing the method
US4498588A (en) * 1984-05-03 1985-02-12 Champion International Corporation Reclosable packaging system and method for forming same
US4653644A (en) * 1984-06-18 1987-03-31 Degesch Gmbh Package for toxic fumigant material in pellet or tablet form and method of making same
JPS6151896A (ja) * 1984-08-21 1986-03-14 株式会社村田製作所 電子部品連
DE3523173A1 (de) * 1985-06-28 1987-01-08 Bramlage Gmbh Spender
DE8518982U1 (de) * 1985-06-29 1986-01-16 Simprop electronic Walter Claas GmbH & Co, 4834 Harsewinkel Bauteile-Spender
GR861995B (en) * 1985-07-30 1986-11-04 Glaxo Group Ltd Devices for administering medicaments to patients
AT384552B (de) * 1985-08-01 1987-12-10 Hurka Wilhelm Inhalationsgeraet zur dosierung und verteilung von festkoerpern in die atemluft
JPS62111825A (ja) * 1985-11-06 1987-05-22 Fuji Kikai Seizo Kk キヤリヤテ−プから電子部品を取り出す方法
US4712460A (en) * 1985-11-18 1987-12-15 Biotrack, Inc. Integrated drug dosage form and metering system
US4735341A (en) * 1986-05-12 1988-04-05 Universal Instruments Corporation Feeder for electrical component supply tapes
US4733797A (en) * 1986-09-22 1988-03-29 Haber Terry M Dosage sealing, monitoring and dispensing assembly
US4958053A (en) * 1987-05-04 1990-09-18 Illinois Tool Works, Inc. Carrier tape and method of manufacturing the same
JPS63277166A (ja) * 1987-05-09 1988-11-15 Hitachi Ltd チツプ電子部品供給装置
US4889731A (en) * 1988-02-12 1989-12-26 W. R. Grace & Co.-Conn. Package having peelable film
CH678151A5 (en) * 1988-07-13 1991-08-15 Heinz Hermann Weick Self-medication nasal dispenser
GB2223001A (en) * 1988-08-17 1990-03-28 C G M Limited Tablets packaging
GB8821287D0 (en) * 1988-09-12 1988-10-12 Ici Plc Device
GB8909891D0 (en) * 1989-04-28 1989-06-14 Riker Laboratories Inc Device
ES2087911T3 (es) * 1989-04-28 1996-08-01 Riker Laboratories Inc Dispositivo de inhalacion de polvo seco.
US5239991A (en) * 1989-06-21 1993-08-31 Fisons Plc Disposable powder medicament inhalation device with peel-off cover
GB8914223D0 (en) * 1989-06-21 1989-08-09 Fisons Plc Medicament container
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
GB9015522D0 (en) * 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
IT1243344B (it) * 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
GB2246555A (en) * 1990-07-19 1992-02-05 Christopher George Packaging for medicine
GB9016789D0 (en) * 1990-07-31 1990-09-12 Lilly Industries Ltd Medicament administering devices
SE9002895D0 (sv) * 1990-09-12 1990-09-12 Astra Ab Inhalation devices for dispensing powders i
FR2667509B1 (fr) * 1990-10-04 1995-08-25 Valois Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
US5042472A (en) * 1990-10-15 1991-08-27 Merck & Co., Inc. Powder inhaler device
US5469843A (en) * 1991-11-12 1995-11-28 Minnesota Mining And Manufacturing Company Inhalation device
US5402472A (en) * 1992-04-23 1995-03-28 Boston Technology, Inc. Automated attendant for any combination of PBX, centrex, and single-line telephones
US5785049A (en) * 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
SE9203570D0 (sv) * 1992-11-27 1992-11-27 Astra Ab Inhaler for multiple use
GB9314614D0 (en) * 1993-07-14 1993-08-25 Minnesota Mining & Mfg Dry powder inhalers
NZ277290A (en) * 1993-12-18 1998-03-25 Merck Patent Gmbh Replacement cartridge for a powder inhalator has doses dispensed from helically arranged compartments
US5694920A (en) * 1996-01-25 1997-12-09 Abrams; Andrew L. Inhalation device

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101400398B (zh) * 2006-05-09 2012-01-18 季米特里奥斯·彭塔弗拉加斯 用于同时施予一种以上的药剂的干粉吸入装置
CN103252006A (zh) * 2007-07-06 2013-08-21 维克多瑞传送设备有限公司 吸入器
CN103252006B (zh) * 2007-07-06 2016-08-03 维克多瑞传送设备有限公司 吸入器
CN106139335A (zh) * 2015-04-09 2016-11-23 正大天晴药业集团股份有限公司 一种药粉释放装置

Also Published As

Publication number Publication date
FR2659558A1 (fr) 1991-09-20
IE910698A1 (en) 1991-09-11
GB9104322D0 (en) 1991-04-17
GB2242134B (en) 1994-10-19
FR2659558B1 (fr) 1993-01-15
IL97396A0 (en) 1992-06-21
CN1066036C (zh) 2001-05-23
GB9004781D0 (en) 1990-04-25
ITRM910145A0 (it) 1991-03-01
LU87898A1 (fr) 1992-11-16
CA2037421A1 (en) 1991-09-03
SE512934C2 (sv) 2000-06-05
AU7202591A (en) 1991-09-05
ES2031763A6 (es) 1992-12-16
BR9100843A (pt) 1991-11-05
CA2037421C (en) 2001-12-18
CN1054893A (zh) 1991-10-02
FI911037A (fi) 1991-09-03
DK37991D0 (da) 1991-03-01
FI107883B (fi) 2001-10-31
AP9100321A0 (en) 1991-10-31
PT96920B (pt) 1999-01-29
FI110991B (fi) 2003-05-15
PL289264A1 (en) 1992-06-01
NO305786B1 (no) 1999-07-26
GB2242134A (en) 1991-09-25
FI990115A0 (fi) 1999-01-21
BE1003798A4 (fr) 1992-06-16
NO910836D0 (no) 1991-03-01
RU2075977C1 (ru) 1997-03-27
NO302929B1 (no) 1998-05-11
NO980033D0 (no) 1998-01-05
AU675825B2 (en) 1997-02-20
IL97396A (en) 1995-12-31
SE9100582L (sv) 1991-09-03
CH683319A5 (de) 1994-02-28
FI990115A (fi) 1999-01-21
GR910100096A (el) 1992-06-30
US5590645A (en) 1997-01-07
CZ180796A3 (cs) 1998-12-16
ITRM910145A1 (it) 1992-09-01
FR2660550A1 (fr) 1991-10-11
HK18895A (en) 1995-02-17
PT96920A (pt) 1993-01-29
ATA43791A (de) 1995-10-15
FR2660550B1 (zh) 1995-01-13
GR1002387B (el) 1996-07-03
JP3110477B2 (ja) 2000-11-20
PL167736B1 (pl) 1995-10-31
OA09393A (fr) 1992-09-15
US5873360A (en) 1999-02-23
KR100210412B1 (ko) 1999-07-15
NL193930C (nl) 2001-03-02
AU5926794A (en) 1994-06-16
US6032666A (en) 2000-03-07
US5860419A (en) 1999-01-19
IE64503B1 (en) 1995-08-09
AU645056B2 (en) 1994-01-06
HK19195A (en) 1995-02-17
CY2010A (en) 1998-02-20
ZA911516B (en) 1992-02-26
JPH04220266A (ja) 1992-08-11
IT1244655B (it) 1994-08-08
DK37991A (da) 1991-09-03
FI911037A0 (fi) 1991-03-01
DE4106379A1 (de) 1991-09-05
NL193930B (nl) 2000-11-01
AT401007B (de) 1996-05-28
KR920005693A (ko) 1992-04-03
CN1030491C (zh) 1995-12-13
NZ237274A (en) 1996-02-27
AP310A (en) 1994-01-07
NL9100381A (nl) 1991-10-01
NO910836L (no) 1991-09-03
NO980033L (no) 1998-01-05
CZ285501B6 (cs) 1999-08-11
SE9100582D0 (sv) 1991-03-01
CZ283168B6 (cs) 1998-01-14
DE4106379C2 (de) 1998-09-24
DK175075B1 (da) 2004-05-24

Similar Documents

Publication Publication Date Title
CN1066036C (zh) 用于吸入装置的药物包
CN100518845C (zh) 吸入器
US6536427B2 (en) Inhalation device
US6792945B2 (en) Inhalation device
US7225808B2 (en) Inhalation device
CN1255867A (zh) 吸入器具
JP2004537377A (ja) 製薬組成物を有する吸入装置
CN1251536A (zh) 药物释放和包装
GB2274273A (en) Medicament pack
CN108261595A (zh) 药带和包括该药带的吸粉器
CN207125954U (zh) 药带和包括该药带的吸粉器
SE513622C2 (sv) Läkemedelsförpackning för användning i en inhalationsanordning
NZ260140A (en) Powder medicament pockets on elongate peelable strip
CA2288413A1 (en) Medicament pack for use in treating respiratory disorders

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20110301

Granted publication date: 20010523